{"title":"Drugs and Laxative Devices for Constipation","description":"\u003cp\u003eOver-the-counter laxatives for occasional constipation: stimulants in tablets and drops, osmotics in sachets based on macrogol and lactulose, mass laxatives with fibre, glycerol suppositories and ready-to-use fast-acting enemas. Sizes for adults and children, to be used for short periods. Fast shipping in 24\/48 hours.\u003c\/p\u003e","products":[{"product_id":"pursennid-30-compresse-lassative-12-mg","title":"Pursennid 40 Laxative Tablets 12 mg","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne coated tablet contains: - Active ingredient: sennosides A + B (as calcium salts) 12 mg. - Excipients with known effects: lactose monohydrate; anhydrous glucose; sucrose. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eLactose monohydrate\u003c\/b\u003e; stearic acid; talc; corn starch; \u003cb\u003eanhydrous glucose\u003c\/b\u003e; \u003cb\u003esucrose\u003c\/b\u003e; gum arabic; anhydrous colloidal silica; titanium dioxide; cetyl palmitate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Contraindicated if the following medical conditions exist: - Inflammatory diseases of the digestive system (i.e. Crohn's disease, ulcerative colitis, liver disease, peritonitis and inflammatory intestinal diseases); - Irritation or obstruction of the gastrointestinal tract (i.e. spastic constipation, obstruction of the ileum\/preileum, cramps and pain, nausea, vomiting and colic); - Abdominal symptoms that may be due to an undiagnosed underlying condition, such as acute intestinal conditions that may require surgery (i.e. acute diverticulitis, appendicitis and massive diarrhea); - states of severe dehydration, with loss of water and electrolytes, especially hypokalemia. Contraindicated in children under 10 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDosage\u003c\/b\u003e Adults and children over 12 years of age: 2-4 coated tablets per day. Children between 10 and 12 years: 1-2 coated tablets per day. After a short period of treatment without appreciable results, consult your doctor. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. \u003cb\u003ePediatric population\u003c\/b\u003e Contraindicated in children under 10 years of age. \u003cb\u003eMethod of administration\u003c\/b\u003e Take preferably in the evening. The action of Pursennid occurs after 6-12 hours. Administered in the evening, the effect of Pursennid appears the following morning. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe established dose must not be exceeded. Prolonged indiscriminate use of laxatives can lead to addiction and a deterioration of intestinal functions. The lowest effective dosage should be used to restore normal intestinal function. If no improvement has been achieved in the intestine, the dosage can be increased under medical supervision. Products containing senna and sennosides should only be used if a therapeutic effect cannot be achieved through a change in diet or the administration of bulking agents. The use of these drugs requires medical supervision: - if there are no positive effects following the treatment; - if use is prolonged beyond one week of treatment; - if symptoms persist or worsen; - after a laparotomy or abdominal surgery; - if a skin rash is present, because it can be a sign of hypersensitivity; - if nausea and vomiting are present, because these symptoms may be signs of a potential or existing intestinal blockage (ileus); - in children between 10 and 12 years old. \u003cu\u003eInformation relating to excipients\u003c\/u\u003e - Lactose: patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine. - Glucose: patients suffering from rare problems of glucose-galactose malabsorption should not take this medicine. - Sucrose: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant use of other drugs that induce hypokalemia (i.e. diuretics, adrenocorticosteroids and licorice) may increase electrolyte imbalance. Hypokalemia (resulting from abuse of laxatives taken for a long time) enhances the action of cardiac glycosides and interferes with antiarrhythmic drugs, with other drugs that induce the return to sinus rhythm (quinidine) and with drugs that induce prolongation of the Q-T interval.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine may cause mild abdominal discomfort such as abdominal pain, cramps, irritation of the colonic and gastric mucosa. Other effects such as dehydration, hypotension, fatigue, myopathies, stomach pain, hyponatremia, renal disorders, secondary hyperaldosteronism, hypocalcemia and hypomagnesemia have also been reported. These adverse reactions are usually reversible once you stop taking the laxative. Prolonged use or overdose of this drug may cause nausea, diarrhea with excessive loss of electrolytes, especially potassium (hypokalemia). There is also the possibility of developing megacolon. During treatment, a yellow-brownish coloration (pH-dependent) of the urine may occur due to metabolites, which has no clinical significance. Habituation has been reported after prolonged treatment. Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as: \u003ci\u003every common\u003c\/i\u003e (≥ 1\/10), \u003ci\u003ecommon\u003c\/i\u003e (≥ 1\/100, \u0026lt; 1\/10); \u003ci\u003euncommon\u003c\/i\u003e (≥ 1\/1.000, \u0026lt; 1\/100); \u003ci\u003erare\u003c\/i\u003e (≥ 1\/10.000; \u0026lt; 1\/1.000); \u003ci\u003every rare\u003c\/i\u003e (\u003c 1\/10,000), or \u003ci\u003enot known\u003c\/i\u003e (frequency cannot be estimated from the available data). \u003cb\u003eTable 4-1 Undesirable effects in the post-marketing experience \u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypersensitivity reactions (itching, urticaria, local or generalized rash).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Megacolon.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Nausea.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Abdominal discomfort.\u003c\/p\u003e\n\u003cp\u003eNot known.\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Fatigue.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Drug tolerance.\u003c\/p\u003e\n\u003cp\u003ePathologies of the musculoskeletal system and connective tissue.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Myopathy.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Kidney problems.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Chromaturia.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hyperaldosteronism.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypocalcemia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypomagnesemia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Dehydration.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypokalemia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hyponatremia.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Decreased blood electrolytes.\u003c\/p\u003e\n\u003cp\u003eVascular pathologies.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse event: Hypotension.\u003c\/p\u003e\n\u003cp\u003eThe adverse events listed above are based on spontaneous post-marketing reports and represent a less precise estimate of the incidence that would be obtained in clinical trials. \u003cb\u003ePediatric population\u003c\/b\u003e The same frequency, type and severity of adverse events are expected in children and adults. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSymptoms\u003c\/b\u003e The most important symptoms related to overdose\/excessive use are abdominal colic and severe diarrhea resulting in losses of fluids and electrolytes, which must be replaced. Diarrhea especially can cause potassium loss, which can lead to cardiac disorders and muscular asthenia, particularly when cardiac glycosides, diuretics, adrenocorticosteroids or licorice root are administered at the same time. \u003cb\u003eManagement\u003c\/b\u003e Treatment must be supportive with generous quantities of fluids. Electrolytes, especially potassium, should be monitored. This is especially important in the elderly. Chronic overdose of anthraquinone drugs can cause toxic hepatitis. Further treatment modalities should take into account clinical indications or poison control center recommendation, where available.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate data on the use of sennosides in pregnant women. Animal studies have not shown reproductive toxicity. The potential risk for humans is unknown. Pregnant women should consult their doctor before taking this medicine. \u003cu\u003eBreastfeeding\u003c\/u\u003e Use during breastfeeding is not recommended as there are insufficient data on the excretion of the metabolites in breast milk. Small quantities of metabolites (rein) are excreted in breast milk. No laxative effect has been reported on breast-fed infants. \u003cu\u003eFertility\u003c\/u\u003e Preclinical studies with sennosides do not indicate particular risks for fertility at therapeutically relevant doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine has no or negligible influence on the ability to drive or use machinery.\u003c\/p\u003e","brand":"Gsk","offers":[{"title":"Default Title","offer_id":40207823732851,"sku":"004758025","price":12.28,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/glaxosmithkline-c-health-spa-pursennid-30-compresse-lassative-12-mg-farmacia-dottor-tili-1213792748.jpg?v=1767125872"},{"product_id":"glicerolo-carlo-erba-18-supposte-2250-mg","title":"Glycerol Carlo Erba 18 Suppositories 2250 mg.","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL CARLO ERBA Early childhood 900 mg suppositories\u003c\/i\u003e An early childhood suppository contains: active ingredient: Glycerol 900 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 1375 mg\u003c\/i\u003e \u003ci\u003esuppositories\u003c\/i\u003e One children's suppository contains: active ingredient: Glycerol 1375 mg. \u003ci\u003eGLYCEROL CARLO ERBA Adults 2250 mg suppositories\u003c\/i\u003e An adult suppository contains: active ingredient: Glycerol 2250 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 2.25 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 2.25 g. \u003ci\u003eGLYCEROL CARLO ERBA Adults 6.75 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 6.75 g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSuppositories\u003c\/u\u003e: sodium stearate; sodium carbonate. \u003cu\u003eRectal solution\u003c\/u\u003e: chamomile fluid extract; mauve fluid extract; wheat starch; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• hypersensitivity to the active ingredient or to any of the excipients; • acute abdominal pain or pain of unknown origin; • nausea or vomiting; • intestinal obstruction or stricture; • rectal bleeding of unknown origin; • acute hemorrhoidal crisis with pain and bleeding; • severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003cu\u003eDosage\u003c\/u\u003e \u003cb\u003eSuppositories\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 2 – 11 years\u003c\/u\u003e: 1 suppository for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 1 month and 2 years\u003c\/u\u003e: 1 early childhood suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cb\u003eRectal solution\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 6 – 11 years\u003c\/u\u003e: 1 or 2 single-dose containers for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 2 – 6 years\u003c\/u\u003e: 1 single-dose container for children as needed for a maximum of 1 or 2 administrations per day. \u003cu\u003eMethod of administration\u003c\/u\u003e \u003cu\u003eSuppositories\u003c\/u\u003e: Remove the suppository from its container and then, if necessary, moisten it to facilitate rectal introduction. If the suppositories appear softened, immerse the containers in cold water before opening them. \u003cu\u003eRectal solution\u003c\/u\u003e: To remove the safety cannula cover from the single-dose container, place your index finger and thumb on the round ring placed above the bellows and, with the other hand, bend the cannula cover until it detaches from the body of the container. During the operation, never grasp the bellows, otherwise the medicine would leak before use. It may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original packaging to protect the medicine from humidity and away from direct sources of heat.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects observed during treatment in clinical studies and integrated with those collected during post-marketing experience are listed in the table below according to System Organ Class (using MedDRA terminology) and according to the following frequency: Very common ≥1\/10; Common ≥1\/100, \u003c1\/10; Uncommon ≥1\/1,000, \u003c1\/100; Rare ≥1\/10,000, \u003c1\/1,000; Very rare \u003c1\/10,000; Not known (frequency cannot be estimated from the available data). The available data are insufficient to establish the frequency of the individual effects listed.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known: Cramp-like pain in the abdomen*; abdominal colic, diarrhea**, anal irritation.\u003c\/p\u003e\n\u003cp\u003e*usually isolated ** with loss of fluids and electrolytes Isolated cramping pain or abdominal colic and diarrhea are more frequent in cases of severe constipation. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \"www.agenziafarmaco.gov.it\/it\/responsabili\".\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives – frequent or prolonged use or with excessive doses) can cause abdominal pain and persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more serious cases, the onset of dehydration or hypokalaemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGlycerol has no influence on the ability to drive vehicles and use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Carlo Erba","offers":[{"title":"Default Title","offer_id":40207823896691,"sku":"029651039","price":6.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/carlo-erba-otc-srl-glicerolo-carlo-erba-18-supposte-2250-mg-farmacia-dottor-tili-1213792744.jpg?v=1767125952"},{"product_id":"verolax-ad-rettale-6-clismi-6-75g","title":"Verolax AD Rectal 6 Enemas 6.75g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConstipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eVerolax “6.75 g Adults Rectal Solution” 6 Single-dose Containers 9 G\u003c\/i\u003e: Each 9G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 6.75 g \u003ci\u003eVerolax “2.25 g Children Rectal Solution” 6 Single-dose Containers 3 G\u003c\/i\u003e: Each 3G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “2.25 g Adult Suppositories” 18 Suppositories\u003c\/i\u003e:Each adult suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “1,375 g Children Suppositories” 18 Suppositories\u003c\/i\u003e: Each children's suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 1.375 g \u003ci\u003eVerolax “0.675 g Infant Suppositories” 12 Suppositories\u003c\/i\u003e: Each infant suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 0.675 g\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution for adults and children:\u003c\/i\u003e Mallow fluid extract; Chamomile fluid extract; Wheat starch; Purified water. \u003ci\u003eSuppositories Adults, Children, Infants:\u003c\/i\u003e Sodium stearate, Sodium carbonate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndividual hypersensitivity confirmed towards the product. Anorectal diseases, hemorrhagic rectocolitis and inflammation of hemorrhoids. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution:\u003c\/i\u003e 1 or 2 single-dose containers in 24 hours. In case of stubborn constipation, no more than 2 doses can be introduced into the rectum at the same time. \u003ci\u003eSuppositories:\u003c\/i\u003e 1 suppository as needed. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo special precautions for storage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe continuous use of laxatives can cause addiction or damage of various types. Do not use laxatives if abdominal pain, nausea and vomiting are present. If constipation is stubborn, consult your doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interactions with other drugs have been found. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe only effects that may be encountered are irritative, at the level of the rectal area. These are usually mild forms, which do not require medical intervention.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known symptoms of overdose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBased on its chemical-physical properties, rectal glycerin can be usefully used during pregnancy or the puerperium.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTaking the drug does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Angelini","offers":[{"title":"Default Title","offer_id":40207824453747,"sku":"026525055","price":5.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-verolax-ad-rettale-6-clismi-6-75g-farmacia-dottor-tili-1254215759.jpg?v=1786737460"},{"product_id":"lattulosio-sand-sciroppo-180-ml","title":"Lactulose Sand Syrup 180 ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation. \u003cu\u003eAdults:\u003c\/u\u003e occasional constipation; adjuvant in intestinal bacterial diseases caused by coliform germs (Salmonella, Shigella, etc.) \u003cu\u003eChildren and infants:\u003c\/u\u003e constipation; treatment of putrefactive syndromes due to eating disorders; as a corrective to the infant's diet, especially in the transition from maternal to artificial breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e66.7% syrup, 180 ml bottle\u003c\/u\u003e 100 ml of syrup contains 66.7 g of lactulose Excipients with known effect: 100 ml of syrup contains 0.118 g of sodium benzoate. For the complete list of excipients see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003esodium benzoate; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Laxatives are contraindicated in subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Contraindicated in subjects suffering from galactosemia. Generally contraindicated in pediatric age (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage \u003cu\u003eAdults: \u003c\/u\u003ethe average daily dosage is 10-15 g in two administrations. This dosage can be doubled or halved depending on the individual response or clinical picture. Pediatric population \u003cu\u003eChildren:\u003c\/u\u003e from 2.5 to 10 g\/day, even in a single administration, depending on the age and severity of the case. \u003cu\u003eInfants:\u003c\/u\u003e on average 2.5 g per day. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Take preferably in the evening. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSpecial warnings\u003c\/u\u003e Lactulose is absorbed to a very small extent and has no caloric value. However, in addition to lactulose, Lactulose Sandoz also contains galactose, lactose and small quantities of other sugars. This must be taken into account in the treatment of diabetic patients and in patients following low-calorie diets. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). \u003cu\u003ePrecautions for use\u003c\/u\u003e Do not use the medicine if abdominal pain, nausea and vomiting are present. If constipation is stubborn, consult a doctor. In patients who present disorders caused by excessive intestinal meteorism it is advisable to start treatment with the minimum doses indicated; these doses can be gradually increased in relation to the patient's response. In children under 12 years of age the medicine can only be used after consulting a doctor. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of medicines and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. \u003cb\u003e \u003cu\u003eImportant information about some excipients\u003c\/u\u003e \u003c\/b\u003e Lactulose Sandoz contains 26.4 mg of sodium benzoate per average daily dose equivalent to 0.14 mg\/ml. Sodium benzoate may increase jaundice (yellowing of the skin and eyes) in newborns up to 4 weeks of age. The increase in bilirubin following its detachment from albumin can increase neonatal jaundice which can progress to kernicterus (deposits of unconjugated bilirubin in the brain tissue). Lactulose Sandoz contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBroad-spectrum antibacterial agents, administered orally at the same time as lactulose, can reduce degradation, limiting the possibility of acidification of the intestinal contents and consequently the therapeutic efficacy. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other medicines administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Occasionally: isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. Frequency not known: flatulence. Immune system disorders: Frequency not known: hypersensitivity reactions. Skin and subcutaneous tissue disorders: Frequency not known: rash, itching, urticaria. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLactulose sandoz does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Sandoz","offers":[{"title":"Default Title","offer_id":40207839035507,"sku":"027668019","price":7.49,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sandoz-lattulosio-sand-sciroppo-180-ml-farmacia-dottor-tili-1254215794.jpg?v=1786737131"},{"product_id":"aboca-sollievo-fisiolax-90-compresse","title":"Aboca Relief Fisiolax 90 Tablets","description":"\u003cp\u003eAboca Sollievo Fisiolax is a medical device based on senna, chicory, fennel, dandelion, caraway and cumin. It works with a \u003cstrong\u003elaxative effect in case of constipation\u003c\/strong\u003e, protects the intestinal mucosa from inflammation and irritation, \u003cstrong\u003enaturally stimulates intestinal motility\u003c\/strong\u003e promoting the \u003cstrong\u003eintestinal contractions\u003c\/strong\u003e and drawing water into the intestine for \u003cstrong\u003esoften the stool and facilitate evacuation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe action of Aboca Sollievo FisioLax is obtained thanks to the set of natural active ingredients that act on the functions used by the intestine to regulate transit. These determine a natural laxative action, a propulsive effect on intestinal transit and a protective effect on the intestinal mucosa as Aboca Sollievo FisioLax:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCause a \u003cstrong\u003eincreased intestinal motility\u003c\/strong\u003e, promoting the contraction of the intestine.\u003c\/li\u003e\n\u003cli\u003eIt favors the\u003cstrong\u003ehydration of feces\u003c\/strong\u003e, reducing the reabsorption of water in the intestine.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForms a barrier\u003c\/strong\u003e which adheres to the intestinal mucosa for a \u003cstrong\u003ecomplete protection of the intestinal wall.\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eModulates inflammation\u003c\/strong\u003e which is counteracted by the protective barrier of the mucosa\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eMethod of use and dosage of Aboca Sollievo Fisiolax\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAverage analysis 1 tablet Aboca Sollievo FisioLax\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFisiolax Relief Complex 420mg\u003cbr\u003ePolyphenolic complex with flavonoids and sennosides ≥ 3.1%\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWarnings and Contraindications Aboca Sollievo Fisiolax\u003c\/strong\u003e\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Aboca Sollievo Fisiolax 90 Tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on senna, chicory, fennel, dandelion, caraway and cumin, indicated for the relief of constipation; promotes intestinal motility and hydration of feces, exerting a protective action on the intestinal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Aboca Sollievo Fisiolax 90 Tablets contain?\u003c\/h3\u003e\u003cp\u003eFisiolax Relief Complex (senna, chicory, fennel, dandelion, caraway and cumin).\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAverage values for 1 tablet\u003c\/strong\u003e\u003cbr\u003eFisiolax Relief Complex (obtained from senna, chicory, fennel, dandelion, caraway and cumin): 420 mg\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Aboca Sollievo Fisiolax 90 Tablets?\u003c\/h3\u003e\u003cp\u003eIt is recommended to take 1 to 3 tablets in the evening, when you feel they are useful, with a large glass of water. The correct dosage is the minimum sufficient to promote physiological intestinal transit without producing liquid stools, and can therefore be customized according to individual needs. In general, to promote intestinal transit, it is recommended to drink throughout the day, take the right amount of fiber and do physical activity.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Aboca Sollievo Fisiolax 90 Tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eDo not exceed the maximum recommended dose.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eIn case of persistent constipation, it is important to consult your doctor.\u003cbr\u003eThe product is recommended from 12 years of age.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Aboca Sollievo Fisiolax 90 Tablets stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature, in a cool, dry place away from light.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Aboca Sollievo Fisiolax 90 Tablets?\u003c\/h3\u003e\u003cp\u003eBottle containing 90 tablets of 420 mg\u003cbr\u003eNet Weight: 37.8g\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":40720992665715,"sku":"981920933","price":19.07,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/aboca-spa-societa-agricola-aboca-sollievo-fisiolax-90-compresse-farmacia-dottor-tili-1213792520.jpg?v=1767131052"},{"product_id":"laevolac-sciroppo-stitichezza-180-ml","title":"Laevolac Constipation Syrup 180 ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and children\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLAEVOLAC 66.7 g\/100 ml syrup 100 ml of syrup contain: active ingredient: lactulose 66.7 g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSyrup: none.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• Hypersensitivity to lactulose or to any of the excipients listed in section 6.1. • Acute abdominal pain or pain of unknown origin, • nausea or vomiting, • intestinal obstruction or stenosis, • rectal bleeding of unknown origin, • severe dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eDosage\u003c\/i\u003e The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is recommended to initially use the minimum doses envisaged. Do not exceed the maximum recommended daily dose. \u003cb\u003eAdults \u003c\/b\u003e The recommended dose is 15 - 30 ml (corresponding to 10 - 20 g of lactulose) to be taken in one or two administrations per day. When necessary the dose can be increased. The maximum daily dose is 45 ml (corresponding to 30 g of lactulose). \u003cb\u003eAdolescents and children ≥ 10 years \u003c\/b\u003e The recommended dose is 15 ml (corresponding to 10 g of lactulose) to be taken in one or two doses per day. The maximum daily dose is 15 ml. \u003cb\u003eChildren 5 - \u003c 10 years\u003c\/b\u003e The recommended dose is 10 ml (corresponding to 6.67 g of lactulose) to be taken in one or two administrations per day. The maximum daily dose is 10 ml. \u003cb\u003eChildren \u003e1 - \u003c 5 years\u003c\/b\u003e The recommended dose is 5 ml (corresponding to 3.33 g of lactulose) to be taken in one or two administrations per day. The maximum daily dose is 5 ml. \u003cb\u003eChildren 1 month - 1 year\u003c\/b\u003e The recommended dose is 2.5 ml (corresponding to 1.66 g of lactulose) to be taken in a single administration in the evening. The maximum daily dose is 2.5 ml. \u003ci\u003eDuration of treatment\u003c\/i\u003e Laxatives should be used as infrequently as possible and for no longer than seven days. The prescription for prolonged use must be established after adequate clinical evaluation. \u003ci\u003eMethod of administration\u003c\/i\u003e In case of single daily administration, take preferably in the evening. If the dose is divided into two administrations per day, take preferably in the morning and in the evening.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSyrup: Store below 25°C. Shelf life after first opening the bottle: 12 months if stored at temperatures below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings:\u003c\/u\u003e Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact ones (stimulant laxatives), can cause addiction (possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). If diarrhea appears, therapy should be suspended. LAEVOLAC contains galactose and lactose. Patients with rare hereditary problems of galactose intolerance, e.g. galactosemia, or glucose-galactose malabsorption, should not take this medicine. LAEVOLAC contains fructose. The additive effect of co-administration of medicinal products containing fructose (or sorbitol) and dietary intake of fructose (or sorbitol) should be considered.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Laevolac may lead to increased toxicity of digitalis due to potassium depletion. A synergistic effect with neomycin is possible. Broad-spectrum antibacterial agents, administered orally at the same time as lactulose, can reduce its degradation, limiting the possibility of acidification of the intestinal contents and, consequently, the therapeutic efficacy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following are the side effects organized according to the MedDRA System Organ classification. The frequency is defined as follows: very common (≥1\/10), common (≥1\/100 to \u003c1\/10), uncommon (≥1\/1000 to \u003c1\/100), rare (≥1\/10,000 to \u003c1\/1000), very rare (\u003c1\/10,000), not known (the frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Very common. Side effect: Abdominal pain, flatulence.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Common. Side effect: Abdominal distention, urgency of evacuation, diarrhea, nausea.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Uncommon. Side effect: Vomiting.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and conditions relating to the administration site - Frequency: Common. Side effect: Reduced appetite.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Frequency: Common. Side effect: Headache.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders - Frequency: Not known. Side effect: Electrolyte depletion.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Not known. Side effect: Hypersensitivity reactions\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Frequency: Not known. Side effect: Skin rash, itching, urticaria.\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea, in which case treatment should be suspended and the resulting losses of fluids and electrolytes must be replenished.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or during breastfeeding. The use of LAEVOLAC should be considered only in case of actual need and if the expected benefit for the mother outweighs the risk for the child.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaevolac does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Chiesi","offers":[{"title":"Default Title","offer_id":46369303200071,"sku":"029565013","price":9.69,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/chiesi-farmaceutici-spa-laevolac-sciroppo-stitichezza-180-ml-farmacia-dottor-tili-1213792502.webp?v=1767131379"},{"product_id":"glicerolo-carlo-erba-6-microclismi-soluzione-rettale-6-75g","title":"Glycerol Carlo Erba 6 Microenemas Rectal Solution 6,75g.","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL CARLO ERBA Early childhood 900 mg suppositories\u003c\/i\u003e An early childhood suppository contains: active ingredient: Glycerol 900 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 1375 mg\u003c\/i\u003e \u003ci\u003esuppositories\u003c\/i\u003e One children's suppository contains: active ingredient: Glycerol 1375 mg. \u003ci\u003eGLYCEROL CARLO ERBA Adults 2250 mg suppositories\u003c\/i\u003e An adult suppository contains: active ingredient: Glycerol 2250 mg. \u003ci\u003eGLYCEROL CARLO ERBA Children 2.25 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 2.25 g. \u003ci\u003eGLYCEROL CARLO ERBA Adults 6.75 g rectal solution\u003c\/i\u003e Each single-dose container contains: active ingredient: Glycerol 6.75 g. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSuppositories\u003c\/u\u003e: sodium stearate; sodium carbonate. \u003cu\u003eRectal solution\u003c\/u\u003e: chamomile fluid extract; mauve fluid extract; wheat starch; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• hypersensitivity to the active ingredient or to any of the excipients; • acute abdominal pain or pain of unknown origin; • nausea or vomiting; • intestinal obstruction or stricture; • rectal bleeding of unknown origin; • acute hemorrhoidal crisis with pain and bleeding; • severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003cu\u003eDosage\u003c\/u\u003e \u003cb\u003eSuppositories\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 adult suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 2 – 11 years\u003c\/u\u003e: 1 suppository for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 1 month and 2 years\u003c\/u\u003e: 1 early childhood suppository as needed, for a maximum of 1 or 2 administrations per day. \u003cb\u003eRectal solution\u003c\/b\u003e: \u003cu\u003eAdults\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003ePediatric population\u003c\/i\u003e \u003cu\u003eAdolescents (12 – 18 years)\u003c\/u\u003e: 1 single-dose container for adults as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 6 – 11 years\u003c\/u\u003e: 1 or 2 single-dose containers for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged between 2 – 6 years\u003c\/u\u003e: 1 single-dose container for children as needed for a maximum of 1 or 2 administrations per day. \u003cu\u003eMethod of administration\u003c\/u\u003e \u003cu\u003eSuppositories\u003c\/u\u003e: Remove the suppository from its container and then, if necessary, moisten it to facilitate rectal introduction. If the suppositories appear softened, immerse the containers in cold water before opening them. \u003cu\u003eRectal solution\u003c\/u\u003e: To remove the safety cannula cover from the single-dose container, place your index finger and thumb on the round ring placed above the bellows and, with the other hand, bend the cannula cover until it detaches from the body of the container. During the operation, never grasp the bellows, otherwise the medicine would leak before use. It may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original packaging to protect the medicine from humidity and away from direct sources of heat.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects observed during treatment in clinical studies and integrated with those collected during post-marketing experience are listed in the table below according to System Organ Class (using MedDRA terminology) and according to the following frequency: Very common ≥1\/10; Common ≥1\/100, \u003c1\/10; Uncommon ≥1\/1,000, \u003c1\/100; Rare ≥1\/10,000, \u003c1\/1,000; Very rare \u003c1\/10,000; Not known (frequency cannot be estimated from the available data). The available data are insufficient to establish the frequency of the individual effects listed.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known: Cramp-like pain in the abdomen*; abdominal colic, diarrhea**, anal irritation.\u003c\/p\u003e\n\u003cp\u003e*usually isolated ** with loss of fluids and electrolytes Isolated cramping pain or abdominal colic and diarrhea are more frequent in cases of severe constipation. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \"www.agenziafarmaco.gov.it\/it\/responsabili\".\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives – frequent or prolonged use or with excessive doses) can cause abdominal pain and persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more serious cases, the onset of dehydration or hypokalaemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGlycerol has no influence on the ability to drive vehicles and use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Carlo Erba","offers":[{"title":"Default Title","offer_id":46656239042887,"sku":"029651066","price":3.49,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/carlo-erba-otc-srl-glicerolo-carlo-erba-6-microclismi-soluzione-rettale-6-75g-farmacia-dottor-tili-1213792487.jpg?v=1767112571"},{"product_id":"glicerolo-afom-adulti-6-75g-soluzione-rettale-6-contenitori-monodose-con-camomilla-e-malva","title":"Glycerol Afom Adults 6.75g Rectal Solution 6 Single-Dose Containers with Chamomile and Mallow","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL AFOM early childhood 2.25 g rectal solution - 6 single-dose containers with chamomile and mallow\u003c\/i\u003e. Each single-dose container contains: \u003ci\u003eactive ingredients\u003c\/i\u003e: Glycerol 2.25 g. \u003ci\u003eGLYCEROL AFOM children 4.5 g rectal solution - 6 single-dose containers with chamomile and mallow\u003c\/i\u003e. Each single-dose container contains: \u003ci\u003eactive ingredients\u003c\/i\u003e: Glycerol 4.5 g. \u003ci\u003eGLYCEROL AFOM adults 6.75 g rectal solution - 6 single-dose containers with chamomile and mallow.\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eactive ingredients\u003c\/i\u003e: Glycerol 6.75 g. For the complete list of excipients see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eChamomile fluid extract, Mallow fluid extract, Potato starch, Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients, - acute abdominal pain or pain of unknown origin, - nausea or vomiting, - intestinal obstruction or stenosis, - rectal bleeding of unknown origin, - acute haemorrhoidal crisis with pain and bleeding, - severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003cu\u003eAdults and adolescents (12-18 years)\u003c\/u\u003e: 1 single-dose adult container of 6.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 6-11 years\u003c\/u\u003e: 1 single-dose container of 4.5 g for children as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eChildren aged 2-6 years\u003c\/u\u003e: 1 single-dose infant container of 2.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003cu\u003eInstructions for use\u003c\/u\u003e: Remove the cap of the single-dose container; it may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original packaging to protect the medicine from humidity and away from direct sources of heat.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of glycerol organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e: Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives - frequent or prolonged use or with excessive doses) can cause abdominal pain, persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Aeffe Farmaceutici","offers":[{"title":"Default Title","offer_id":50753944453447,"sku":"029916083","price":2.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aeffe-farmaceutici-srl-glicerolo-afom-adulti-6-75g-soluzione-rettale-6-contenitori-monodose-con-camomilla-e-malva-farmacia-dottor-tili-1213792420.jpg?v=1767131746"},{"product_id":"glicerolo-marco-viti-soluzione-rettale-adulti-6-75g-6-contenitori-monodose-con-camomilla-e-malva","title":"Glycerol Marco Viti rectal solution adults 6.75g 6 single-dose containers with chamomile and mallow","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eGLYCEROL MARCO VITI early childhood 2.25 g rectal solution\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: Glycerol 2.25 g \u003ci\u003eGLYCEROL MARCO VITI children 4.5 g rectal solution\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: Glycerol 4.5 g \u003ci\u003eGLYCEROL MARCO VITI adults 6.75 g rectal solution\u003c\/i\u003e Each single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: Glycerol 6.75 g For the complete list of excipients see paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eChamomile fluid extract; mauve fluid extract; pregelatinized starch; purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients, - acute abdominal pain or pain of unknown origin, - nausea or vomiting, - intestinal obstruction or stenosis, - rectal bleeding of unknown origin, - acute haemorrhoidal crisis with pain and bleeding, - severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation. It is advisable to initially use the minimum doses provided. \u003ci\u003eAdults and adolescents (12-18 years)\u003c\/i\u003e: 1 single-dose adult container of 6.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003eChildren aged 6-11 years\u003c\/i\u003e: 1 single-dose container of 4.5 g for children as needed, for a maximum of 1 or 2 administrations per day \u003ci\u003eChildren aged 2-6 years\u003c\/i\u003e: 1 single-dose infant container of 2.75 g as needed, for a maximum of 1 or 2 administrations per day. \u003ci\u003eInstructions for use\u003c\/i\u003e: Remove the cap. During the operation, never grasp the bellows, otherwise the medicine would leak before use. It may be useful to lubricate the cannula with a drop of the solution itself, before introducing it into the rectum and pressing the bellows. Extract the cannula while holding down the bellows. Each container must be used for a single administration only; any residual medicine must be discarded. In children under twelve years of age the medicine can only be used after consulting a doctor. Laxatives should be used as infrequently as possible and for no longer than seven days (see section 4.4). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original package in order to protect the medicine from light.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Abuse of laxatives can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more serious cases of abuse, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo specific interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of glycerol organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e: Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported. In any case, excessive doses (abuse of laxatives - frequent or prolonged use or with excessive doses) can cause abdominal pain, persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo adequate and well-controlled studies have been carried out on the use of the medicine during pregnancy or breastfeeding. Although there are no obvious contraindications to the use of the medicine during pregnancy and breastfeeding, it is recommended to take the medicine only if necessary and under medical supervision.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51130948223303,"sku":"030334080","price":5.12,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-glicerolo-marco-viti-soluzione-rettale-adulti-6-75g-6-contenitori-monodose-con-camomilla-e-malva-farmacia-dottor-tili-1213792421.jpg?v=1767130949"},{"product_id":"clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-133ml","title":"Fleet Enema 21.4g\/9.4g Rectal Solution Ready to Use 133ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and children over 3 years of age; pre- and post-operative intestinal emptying, in obstetrics, in preparation for radioscopic examinations and endoscopic investigations of the last intestinal tract.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach 118 ml dose contains the equivalent of 21.4 g (18.1% w\/v) sodium dihydrogen phosphate dihydrate and 9.4 g (8.0% w\/v) disodium hydrogen phosphate dodecahydrate. Contains 4.4 g of sodium per 118 ml dose delivered. Excipient with known effects: This medicinal product contains 0.0006 g\/ml benzalkonium chloride. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzalkonium chloride Disodium edetate Distilled water q.s.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is contraindicated in patients with: • Hypersensitivity to the active ingredients or to any of the excipients listed in paragraph 6.1. • Conditions causing increased absorptive capacity, decreased elimination capacity, or decreased gastric motility, for example: o   suspected intestinal obstruction o   paralytic ileus o   anorectal stenosis o   perforated anus o   congenital or acquired megacolon o   Hirschsprung's disease. • Undiagnosed gastrointestinal disorders, for example: o   symptoms suggestive of appendicitis, intestinal perforation or active inflammatory bowel disease o   undiagnosed rectal bleeding. • Congestive heart failure. • Dehydration. • Children under 3 years of age. • Clinically significant renal insufficiency. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and children over 12 years of age: 1 bottle (118 ml delivered dose) no more than once a day or as directed by the doctor (see section 4.4). Children aged 3 to 12 years: Half dose no more than once a day or as directed by the doctor (see sections 4.4 and 4.9). Enema Fleet is contraindicated in children under 3 years of age (see paragraph 4.3). In occasional constipation, laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate assessment of the case. Renal insufficiency: Do not administer to patients with clinically significant impairment of renal function (see section 4.3). The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia (see section 4.4). \u003cu\u003eMethod of administration\u003c\/u\u003e For rectal use only: Lie on your left side with both knees bent, arms at rest. Remove the orange protective cap. With constant pressure, gently insert the Comfortip enema into the anus with the cannula pointing towards the navel. Press the bottle until almost all the liquid has come out. Discontinue use if resistance is encountered. Forcing the enema can cause injury. 2 to 5 minutes are enough to obtain the desired effect. For occasional constipation, rectal enemas are used to provide relief and only on a short-term basis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use Clisma Fleet in case of nausea, vomiting or pain. Patients should be advised to expect loose stools and should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans) or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Enema Fleet contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels and consequently hypernatremia, hyperphosphatemia, hypocalcemia and hypokalemia which may occur with clinical signs such as tetany and renal failure. Fluid and electrolyte changes are of particular concern in children with megacolon or any other condition in which there is retention of enema solution, and in patients with comorbidities. This is why Enema Fleet should be used with caution in: • elderly or weakened patients and in patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures); • subjects with colostomy, patients taking diuretics or other medicines that can modify fluid and electrolyte levels; • subjects who are taking medicines known to prolong the QT interval (for example amiodarone, arsenic trioxide, astemizole, azithromycin, erythromycin, clarithromycin, chlorpromazine, cisapride, citalopram, domperidone, terfenadine, procainamide), or with known fluid and electrolyte imbalance, such as hypocalcemia, hypokalemia, hyperphosphatemia, hypernatremia. Also use with caution in patients taking medications known to affect perfusion, renal function, or hydration status. Where there is suspicion of hydroelectrolyte disorders and risk of hyperphosphatemia, hydroelectrolyte levels must be monitored before and after the administration of Fleet Enema. The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia. Repeated and prolonged use of Clisma Fleet is not recommended as it may cause habituation. Administering more than one enema in a 24-hour period may be harmful. Enema Fleet should not be used for more than a week. Clisma Fleet must be administered according to the instructions for use (see paragraph 4.2). Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. Rectal bleeding after using Fleet Enema may indicate a serious condition. In this case the administration must be stopped immediately. In general, evacuation occurs approximately 5 minutes after administration of Fleet Enema, therefore, retention times of more than 5 minutes are not recommended. If evacuation does not occur after using Clisma Fleet or if the retention time lasts more than 10 minutes, serious side effects may occur. No other administrations must be used and the patient's condition must be evaluated in order to identify any hydroelectrolyte alterations and to minimize the risk of severe hyperphosphatemia (see sections 4.8 and 4.9). \u003ci\u003eImportant information about some excipients\u003c\/i\u003e Due to the presence of benzalkonium chloride, the product is irritating and can cause local skin reactions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with caution in patients who are receiving calcium channel blockers, diuretics, lithium or other medicinal products that may affect fluid and electrolyte levels as hyperphosphataemia, hypocalcaemia, hypokalaemia, acidosis and hypernatremic dehydration may occur (see section 4.4). Other preparations with sodium phosphates including oral solutions or sodium phosphate tablets should not be administered simultaneously (see section 4.3). Since hypernatremia is associated with low lithium levels, concomitant use of Fleet Enema and lithium may cause a reduction in serum lithium levels with decreased efficacy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is well tolerated if used as indicated. However, adverse events associated with the use of Enema Fleet have frequently been reported. In some cases, adverse events may occur, especially if the enema is used inappropriately. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Undesirable effects are listed below, by MedDRA system organ class and using the following frequency: very common (≥ 1\/10), common (≥ 1\/100, \u003c1\/10), uncommon (≥ 1\/1,000, \u003c1\/100), rare (≥ 1\/10,000, \u003c1\/1,000), very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data): \u003cu\u003eImmune system disorders\u003c\/u\u003e: Very rare: hypersensitivity e.g. urticaria. \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e: Very rare: blisters, itching, burning. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: Very rare: dehydration, hyperphosphatemia, hypocalcaemia, hypokalaemia, hypernatraemia, metabolic acidosis. \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: Very rare: nausea, vomiting, abdominal pain, abdominal distension, diarrhoea, gastrointestinal pain, anal discomfort and proctalgia. \u003cu\u003eSystemic pathologies and conditions relating to the administration site\u003c\/u\u003e: Very rare: rectal irritation, pain, burning, chills. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFatal cases have been reported after administration of excessive doses, after retention, in case of administration to pediatric patients or in obstructed patients. In case of overdose or retention, hyperphosphatemia, hypocalcemia, hypernatremia, hyperphosphatemia, hypernatremic dehydration, hypokalaemia, hypovolemia, acidosis and tetany may occur. Recovery from toxic effects can normally be achieved by rehydration. Treatment of electrolyte imbalances may require immediate medical intervention through the administration of adequate electrolytes and fluid therapy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince there are no relevant data available to evaluate the potential for fetal malformation or other foetotoxic effects when administered during pregnancy, Fleet Enema should be used under direct medical supervision only at the time of delivery or postpartum. Because sodium phosphate may pass into breast milk, it is recommended that breast milk be expressed and discarded for at least 24 hours after administering Fleet Enema.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eClisma Fleet does not affect the ability to drive and use machinery, but it is necessary to remain near toilets after using this medicine.\u003c\/p\u003e","brand":"Casen Recordati","offers":[{"title":"Default Title","offer_id":51131195883847,"sku":"029319011","price":5.58,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/casen-recordati-sl-clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-133ml-farmacia-dottor-tili-1213792402.jpg?v=1767132647"},{"product_id":"dulcolax-5mg-40-compresse-rivestite","title":"Dulcolax 5mg 40 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS One coated tablet contains: bisacodyl 5 mg. Excipients with known effects: lactose, sucrose, castor oil. ADULTS SUPPOSITORIES One suppository contains: bisacodyl 10 mg. CHILDREN SUPPOSITORIES One suppository contains: bisacodyl 5 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS \u003cb\u003eLactose\u003c\/b\u003e \u003cb\u003emonohydrate\u003c\/b\u003e, corn starch, modified starch, glycerol, magnesium stearate, \u003cb\u003esucrose\u003c\/b\u003e, talc, gum arabic, titanium dioxide (E171), methacrylic acid\/methyl methacrylate copolymer (1:1), methacrylic acid\/methyl methacrylate copolymer (1:2), \u003cb\u003ecastor oil\u003c\/b\u003e, macrogol 6000, iron oxide (E172), white wax, carnauba wax, shellac. SUPPOSITORIES Triglycerides of saturated fatty acids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Dulcolax is also contraindicated in patients with paralytic ileus, acute abdominal conditions, such as appendicitis, and severe abdominal pain associated with nausea and vomiting which may be indicative signs of serious pathological conditions, intestinal obstruction or stenosis, acute inflammation of the gastrointestinal tract, rectal bleeding of unknown origin, severe state of dehydration. Pregnancy and breastfeeding (see section 4.6). The use of Dulcolax is contraindicated in cases of rare hereditary conditions that may be incompatible with the intake of one of the excipients (see section 4.4 \"special warnings and precautions for use\"). Dulcolax is contraindicated in children under 2 years of age. Suppositories are contraindicated in cases of anal fissures and ulcers (perianal pain and bleeding may occur).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS - Adults: 1-2 coated tablets per day. \u003cu\u003ePediatric population\u003c\/u\u003e \u003ci\u003e - \u003c\/i\u003eChildren over 10 years: 1-2 coated tablets per day. - Children aged between 2 and 10 years: 1 coated tablet per day. It is advisable to start with the minimum expected dose. The dose can then be increased, up to the maximum recommended dose, for regular stool evacuation. The maximum daily dose must never be exceeded. \u003cu\u003eInstructions for use\u003c\/u\u003e Take the coated tablets preferably in the evening to determine an evacuation the following morning (after approximately 10 hours). When administered in the morning, on an empty stomach, the effect is obtained after approximately five hours. The coated tablets should not be administered together with products that reduce the acidity of the upper gastrointestinal tract, such as milk, antacids (e.g. bicarbonate) or proton pump inhibitors. The coated tablets should be swallowed whole. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine. SUPPOSITORIES - Adults: 1 adult suppository (10 mg) per day. \u003cu\u003ePediatric population\u003c\/u\u003e - Children over 10 years: 1 adult suppository (10 mg) per day. - Children aged between 2 and 10 years: 1 children's suppository (5 mg) per day. The maximum daily dose must never be exceeded. Children aged 10 years and younger with chronic or persistent constipation should take Dulcolax under their doctor's supervision. Dulcolax must not be administered to children under two years of age. \u003cu\u003eInstructions for use\u003c\/u\u003e The effect of suppositories usually occurs in about 20 minutes (range: 10 - 30 minutes). Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCoated tablets: this medicine does not require any special storage conditions. Suppositories: Do not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings\u003c\/u\u003e Like all laxatives, Dulcolax should not be taken continuously every day or for long periods of time without investigating the cause of the constipation. In case of diabetes mellitus, hypertension or heart disease, use only after consulting your doctor. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Intestinal loss of fluids can cause dehydration. Symptoms may be thirst and oliguria. In patients for whom dehydration may be dangerous (patients with renal insufficiency, elderly patients), treatment with Dulcolax should be stopped and restarted only under medical supervision. Hematochezia (blood in the stool) may occur in patients, which is usually mild and goes away on its own. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Cases of dizziness and\/or syncope have been reported after taking Dulcolax. The data relating to these cases suggest that the events, rather than a phenomenon related to the intake of Dulcolax, could be interpreted as a manifestation of \"defecation syncope\" (attributable to the effort of the act of defecation), or as a vasovagal response to abdominal pain related to the constipation itself. The use of suppositories can lead to painful sensations and local irritation, in particular, in patients with fissures and ulcerative proctitis (see section 4.3 “contraindications”). Stimulant laxatives including Dulcolax do not contribute to weight loss (see section 5.1 “Pharmacodynamic properties”). \u003cb\u003eImportant information about some excipients:\u003c\/b\u003e Dulcolax tablets contain 33.2 mg of \u003cu\u003elactose\u003c\/u\u003e equal to 66.42 mg in case of taking the maximum daily dose, for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine tablets. Dulcolax tablets contain 23.4 mg of \u003cu\u003esucrose\u003c\/u\u003e equal to 46.8 mg when taking the maximum daily dose for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency should not take this medicine tablets. Dulcolax tablets may cause gastric upset and diarrhoea. \u003cu\u003ePrecautions for use\u003c\/u\u003e In children aged between 2 years and 10 years the medicine can only be used after consulting the doctor (see section 4.3). Like all laxatives, it should not be taken daily or for prolonged periods without first evaluating the cause of the constipation. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant administration of diuretics or adrenocorticosteroids and excessive doses of Dulcolax may lead to an increased risk of electrolyte imbalance. This imbalance, in turn, can lead to increased sensitivity to cardiac glycosides. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least two hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of other laxatives may potentiate the gastrointestinal side effects of Dulcolax.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe most commonly reported side effects during treatment with Dulcolax are abdominal pain and diarrhea. \u003cu\u003eImmune system disorders\u003c\/u\u003e: anaphylactic reactions, angioneurotic edema as well as other hypersensitivity reactions. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: dehydration. \u003cu\u003eNervous system disorders\u003c\/u\u003e: dizziness, syncope. The phenomena of dizziness and syncope that occur after taking bisacodyl appear to be attributable to a vasovagal response (resulting, for example, from abdominal pain, or the evacuation of feces). \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: abdominal cramps, abdominal pain, diarrhea, nausea, hematochezia (blood in stool), vomiting, abdominal discomfort, anorectal discomfort, colitis including ischemic colitis. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e \u003cu\u003eReporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: \u003c\/u\u003e \u003cu\u003ehttp:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetta-reazione-avversa.\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e Excessive doses can cause abdominal pain and diarrhea, and significant losses of potassium and other electrolytes. Chronic overdose of Dulcolax, as with other laxatives, can cause chronic diarrhea, abdominal pain, hypokalemia, secondary hyperaldosteronism and kidney stones. Renal tubular injury, metabolic alkalosis, and muscle weakness secondary to hypokalemia have also been described in association with chronic laxative abuse. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives. \u003cu\u003eTreatment\u003c\/u\u003e If action is taken within a short time of ingesting the oral form of Dulcolax, absorption can be reduced or avoided by inducing vomiting or gastric lavage. Fluid and electrolyte losses must be replaced. This is especially important in elderly and young patients. The administration of spasmolytics may be useful.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate and well-controlled studies on the use of the medicine during pregnancy. Therefore, although unwanted or toxic effects have never been reported during pregnancy, like all medicines, Dulcolax must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. \u003cu\u003eFertility\u003c\/u\u003e No studies have been conducted to investigate the effects on human fertility. \u003cu\u003eBreastfeeding\u003c\/u\u003e Clinical data demonstrate that neither the active form of bisacodyl BHPM, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), nor its glucuronic derivatives are excreted in breast milk, however the medicine should only be used if necessary, under direct medical supervision, after evaluating the expected benefit for the mother in relation to the possible risk for the infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies on the effects on the ability to drive and use machines have been performed. However, patients should be informed that due to vasovagal response (e.g., abdominal spasm), dizziness and\/or syncope may occur. If patients experience abdominal spasm they should avoid potentially dangerous activities such as driving or using machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131201257799,"sku":"008997064","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-dulcolax-5mg-40-compresse-rivestite-farmacia-dottor-tili-1258975859.jpg?v=1789561897"},{"product_id":"onligol-macrogol-4000-20-bustine","title":"Onligol Macrogol 4000 20 sachets","description":"\u003cp\u003eOnligol Macrogol 4000 20 sachets is a \u003cstrong\u003epowder laxative for oral solution\u003c\/strong\u003e designed to provide effective relief from chronic and occasional constipation. Its formula based on \u003cstrong\u003eMacrogol 4000\u003c\/strong\u003e it is free of excipients, flavorings and sugars, making it suitable for those looking for a delicate and natural product. Onligol stands out for its ability to \u003cstrong\u003esoften the stool\u003c\/strong\u003e, facilitating evacuation without causing cramps or abdominal pain.\u003c\/p\u003e\n\n\u003cp\u003eThanks to his \u003cstrong\u003eaffinity for water\u003c\/strong\u003e, Onligol acts naturally, without being absorbed or fermented in the intestine, and is eliminated in the feces in unchanged form. This makes it ideal for those who want a treatment that does not irritate the intestinal mucosa. Onligol is versatile and can be dissolved in any drink, such as tea, herbal tea, milk, broth or fruit juice, without altering its flavor, thus offering a pleasant and discreet user experience.\u003c\/p\u003e\n\n\u003cp\u003eSuitable for both adults and children, Onligol offers broad dosing flexibility, allowing you to tailor your intake to individual needs. Its effectiveness does not reduce over time, guaranteeing a \u003cstrong\u003eintestinal relief\u003c\/strong\u003e constant and long-lasting. Onligol is produced by Alfasigma SpA, a trusted brand in the pharmaceutical sector, and is supplied in practical 10g disposable sachets, ideal for quick and easy use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Onligol Macrogol 4000 20 sachets used? What is it for?\u003c\/h3\u003e\u003cp\u003eLaxative based on Macrogol 4000, indicated for the treatment of chronic and occasional constipation; softens the stool, facilitating evacuation without causing cramps or abdominal pain, acting without being absorbed by the intestine.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003eDissolve the dose of product in at least 125 ml (increase up to 150 ml in pediatric age) of any drink, even hot, such as tea, herbal tea, milk, broth or fruit juice. Onligol does not alter the taste of the drink. Drink the reconstituted solution. It is recommended to take Onligol between meals. DOSAGES (unless otherwise prescribed by a doctor): Onligol allows wide dosage flexibility. Adults and children weighing more than 20 kg (11 years): the dose is 10 g (2 level teaspoons), 1-3 times a day, according to individual response. To obtain a faster effect, the maximum daily dose (30 g) can be taken in a single administration. In case of prolonged use, the dose can be reduced to 10 g (2 level teaspoons) 1-2 times a day, even every other day, preferably in the evening. Children 6-9 kg (6 months-1 year): 5 g. Children 10-12 kg (1-2 years): 7.5 g. Children 13-16 kg (2-6 years): 10 g. Children 17-20 kg (6-11 years): 12.5 g. In children up to 20 kg it is recommended to personalize the dose according to the child's real needs until soft stools are obtained.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003eDissolve the dose of product in at least 125 ml (increase up to 150 ml in pediatric age) of any drink, even hot, such as tea, herbal tea, milk, broth or fruit juice. Onligol does not alter the taste of the drink. Drink the reconstituted solution. It is recommended to take Onligol between meals.\u003cbr\u003eDosages (unless otherwise prescribed by a doctor): Onligol allows for wide dosage exibility.\u003cbr\u003eAdults and children weighing more than 20 kg (11 years): the dose is 10 g (2 level teaspoons), 1-3 times a day, according to individual response.\u003cbr\u003eTo obtain a faster effect, the maximum daily dose (30 g) can be taken in a single administration. In case of prolonged use, the dose can be reduced to 10 g (2 level teaspoons) 1-2 times a day, even every other day, preferably in the evening.\u003cbr\u003eChildren 6-9 kg (6 months-1 year): 5 g.\u003cbr\u003eChildren 10-12 kg (1-2 years): 7.5 g.\u003cbr\u003eChildren 13-16 kg (2-6 years): 10 g.\u003cbr\u003eChildren 17-20 kg (6-11 years): 12.5 g.\u003cbr\u003eFor children up to 20 kg it is advisable to personalize the dose according to the child's real needs until soft stools are obtained.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not exceed the maximum daily dosage of 30 g (6 level teaspoons).\u003cbr\u003eDo not take Onligol in case of: known hypersensitivity to macrogol; gastrointestinal perforation and\/or obstruction. During pregnancy and breastfeeding the product must be used upon medical prescription.\u003cbr\u003eDo not use under 6 months. Close the bottle tightly after use.\u003cbr\u003eDuring treatment with Onligol it is advisable to follow an adequate diet, accompanied by the administration of an oral rehydration solution (ORS) to avoid dehydration, however it is advisable to consult your doctor. Do not use Onligol for more than 30 consecutive days, if symptoms persist consult your doctor.\u003cbr\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Onligol Macrogol 4000 20 sachets not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not take Onligol in case of: known hypersensitivity to macrogol; gastrointestinal perforation and\/or obstruction.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan Onligol Macrogol 4000 20 sachets be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cp\u003eDuring pregnancy and breastfeeding the product must be used upon medical prescription.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Onligol Macrogol 4000 20 sachets stored?\u003c\/h3\u003e\u003cp\u003eStore in the original packaging in a cool, dry place.\u003cbr\u003eThe expiry date indicated refers to the product in intact packaging and correctly stored.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Onligol Macrogol 4000 20 sachets?\u003c\/h3\u003e\u003cp\u003e20 disposable sachets of 10 g.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131252670791,"sku":"930327008","price":15.07,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-onligol-macrogol-4000-20-bustine-farmacia-dottor-tili-1213792307.jpg?v=1767143609"},{"product_id":"clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-4-flaconi-133ml","title":"Fleet Enema 21.4g\/9.4g Rectal Solution Ready to Use 4 Bottles 133ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and children over 3 years of age; pre- and post-operative intestinal emptying, in obstetrics, in preparation for radioscopic examinations and endoscopic investigations of the last intestinal tract.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach 118 ml dose contains the equivalent of 21.4 g (18.1% w\/v) sodium dihydrogen phosphate dihydrate and 9.4 g (8.0% w\/v) disodium hydrogen phosphate dodecahydrate. Contains 4.4 g of sodium per 118 ml dose delivered. Excipient with known effects: This medicinal product contains 0.0006 g\/ml benzalkonium chloride. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzalkonium chloride Disodium edetate Distilled water q.s.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is contraindicated in patients with: • Hypersensitivity to the active ingredients or to any of the excipients listed in paragraph 6.1. • Conditions causing increased absorptive capacity, decreased elimination capacity, or decreased gastric motility, for example: o   suspected intestinal obstruction o   paralytic ileus o   anorectal stenosis o   perforated anus o   congenital or acquired megacolon o   Hirschsprung's disease. • Undiagnosed gastrointestinal disorders, for example: o   symptoms suggestive of appendicitis, intestinal perforation or active inflammatory bowel disease o   undiagnosed rectal bleeding. • Congestive heart failure. • Dehydration. • Children under 3 years of age. • Clinically significant renal insufficiency. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and children over 12 years of age: 1 bottle (118 ml delivered dose) no more than once a day or as directed by the doctor (see section 4.4). Children aged 3 to 12 years: Half dose no more than once a day or as directed by the doctor (see sections 4.4 and 4.9). Enema Fleet is contraindicated in children under 3 years of age (see paragraph 4.3). In occasional constipation, laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the case. Renal insufficiency: Do not administer to patients with clinically significant impairment of renal function (see section 4.3). The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia (see section 4.4). \u003cu\u003eMethod of administration\u003c\/u\u003e For rectal use only: Lie on your left side with both knees bent, arms at rest. Remove the orange protective cap. With constant pressure, gently insert the Comfortip enema into the anus with the cannula pointing towards the navel. Press the bottle until almost all the liquid has come out. Discontinue use if resistance is encountered. Forcing the enema can cause injury. 2 to 5 minutes are enough to obtain the desired effect. For occasional constipation, rectal enemas are used to provide relief and only on a short-term basis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use Clisma Fleet in case of nausea, vomiting or pain. Patients should be advised to expect loose stools and should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans) or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Enema Fleet contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels and consequently hypernatremia, hyperphosphatemia, hypocalcemia and hypokalemia which may occur with clinical signs such as tetany and renal failure. Fluid and electrolyte changes are of particular concern in children with megacolon or any other condition in which there is retention of enema solution, and in patients with comorbidities. This is why Enema Fleet should be used with caution in: • elderly or weakened patients and in patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures); • subjects with colostomy, patients taking diuretics or other medicines that can modify fluid and electrolyte levels; • subjects who are taking medicines known to prolong the QT interval (for example amiodarone, arsenic trioxide, astemizole, azithromycin, erythromycin, clarithromycin, chlorpromazine, cisapride, citalopram, domperidone, terfenadine, procainamide), or with known fluid and electrolyte imbalance, such as hypocalcemia, hypokalemia, hyperphosphatemia, hypernatremia. Also use with caution in patients taking medications known to affect perfusion, renal function, or hydration status. Where there is suspicion of hydroelectrolyte disorders and risk of hyperphosphatemia, hydroelectrolyte levels must be monitored before and after the administration of Fleet Enema. The product should be used with caution in patients with impaired renal function, when the clinical benefit is expected to outweigh the risk of hyperphosphatemia. Repeated and prolonged use of Clisma Fleet is not recommended as it may cause habituation. Administering more than one enema in a 24-hour period may be harmful. Enema Fleet should not be used for more than a week. Clisma Fleet must be administered according to the instructions for use (see paragraph 4.2). Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. Rectal bleeding after using Fleet Enema may indicate a serious condition. In this case the administration must be stopped immediately. In general, evacuation occurs approximately 5 minutes after administration of Fleet Enema, therefore, retention times of more than 5 minutes are not recommended. If evacuation does not occur after using Clisma Fleet or if the retention time lasts more than 10 minutes, serious side effects may occur. No other administrations must be used and the patient's condition must be evaluated in order to identify any hydroelectrolyte alterations and to minimize the risk of severe hyperphosphatemia (see sections 4.8 and 4.9). \u003ci\u003eImportant information about some excipients\u003c\/i\u003e Due to the presence of benzalkonium chloride, the product is irritating and can cause local skin reactions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with caution in patients who are receiving calcium channel blockers, diuretics, lithium or other medicinal products that may affect fluid and electrolyte levels as hyperphosphataemia, hypocalcaemia, hypokalaemia, acidosis and hypernatremic dehydration may occur (see section 4.4). Other preparations with sodium phosphates including oral solutions or sodium phosphate tablets should not be administered simultaneously (see section 4.3). Since hypernatremia is associated with low lithium levels, concomitant use of Fleet Enema and lithium may cause a reduction in serum lithium levels with decreased efficacy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnema Fleet is well tolerated if used as indicated. However, adverse events associated with the use of Enema Fleet have frequently been reported. In some cases, adverse events may occur, especially if the enema is used inappropriately. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Undesirable effects are listed below, by MedDRA system organ class and using the following frequency: very common (≥ 1\/10), common (≥ 1\/100, \u003c1\/10), uncommon (≥ 1\/1,000, \u003c1\/100), rare (≥ 1\/10,000, \u003c1\/1,000), very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data): \u003cu\u003eImmune system disorders\u003c\/u\u003e: Very rare: hypersensitivity e.g. urticaria. \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e: Very rare: blisters, itching, burning. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: Very rare: dehydration, hyperphosphatemia, hypocalcaemia, hypokalaemia, hypernatraemia, metabolic acidosis. \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: Very rare: nausea, vomiting, abdominal pain, abdominal distension, diarrhoea, gastrointestinal pain, anal discomfort and proctalgia. \u003cu\u003eSystemic pathologies and conditions relating to the administration site\u003c\/u\u003e: Very rare: rectal irritation, pain, burning, chills. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFatal cases have been reported after administration of excessive doses, after retention, in case of administration to pediatric patients or in obstructed patients. In case of overdose or retention, hyperphosphatemia, hypocalcemia, hypernatremia, hyperphosphatemia, hypernatremic dehydration, hypokalaemia, hypovolemia, acidosis and tetany may occur. Recovery from toxic effects can normally be achieved by rehydration. Treatment of electrolyte imbalances may require immediate medical intervention through the administration of adequate electrolytes and fluid therapy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince there are no relevant data available to evaluate the potential for fetal malformation or other foetotoxic effects when administered during pregnancy, Fleet Enema should be used under direct medical supervision only at the time of delivery or postpartum. Because sodium phosphate may pass into breast milk, it is recommended that breast milk be expressed and discarded for at least 24 hours after administering Fleet Enema.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eClisma Fleet does not affect the ability to drive and use machinery, but it is necessary to remain near toilets after using this medicine.\u003c\/p\u003e","brand":"Casen Recordati","offers":[{"title":"Default Title","offer_id":51131262697799,"sku":"029319023","price":16.46,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/casen-recordati-sl-clisma-fleet-21-4g-9-4g-soluzione-rettale-pronto-per-l-uso-4-flaconi-133ml-farmacia-dottor-tili-1213792287.jpg?v=1767144047"},{"product_id":"clisma-lax-soluzione-rettale-133ml","title":"Clisma Lax rectal solution 133ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml contain 13.91 g of anhydrous monobasic sodium phosphate (NaH\u003csub\u003e2\u003c\/sub\u003ePO\u003csub\u003e4\u003c\/sub\u003e); 3.18 g of dibasic sodium phosphate (Na\u003csub\u003e2\u003c\/sub\u003eHPO\u003csub\u003e4\u003c\/sub\u003e). Excipients with known effects: sodium benzoate (100mg per 100ml) and methylparahydroxybenzoate (50mg per 100ml). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium hydroxide, sodium benzoate, methyl parahydroxybenzoate, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e-Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - acute abdominal pain or of unknown origin - nausea or vomiting - intestinal obstruction or stenosis or anorectal stenosis - intestinal sub-occlusion - mechanical ileus - paralytic ileus - inflammatory intestinal disorders and other conditions that can increase the absorption of the medicine - anal perforation - congenital or acquired megacolon - Hirschsprung's disease - rectal bleeding of unknown origin - acute haemorrhoidal crisis with pain and bleeding - severe state of dehydration - children under the age of twelve. Phosphates are contraindicated in patients with cardiac disorders, severe renal insufficiency or in the presence of hyperphosphatemia. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and adolescents (12-18 years): the entire dose of the bottle. \u003cu\u003eMethod of administration\u003c\/u\u003e Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Take preferably in the evening.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePediatric population\u003c\/u\u003e: The 133 ml bottle should not be used in children under 12 years of age. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Patients should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration, or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans), or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Clisma lax contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels, and consequently hypernatraemia, hyperphosphataemia, hypocalcaemia and hypokalaemia, which may occur with clinical signs such as tetany and renal failure. Abuse of laxatives can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Repeated use of laxatives can give rise to addiction or various types of damage. Prolonged use of a laxative to treat constipation is not recommended. The pharmacological treatment of constipation must be considered an adjuvant to the hygienic-dietary treatment (e.g. increase in vegetable fibers and liquids in the diet, physical activity and re-education of intestinal motility). The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. A careful evaluation by the doctor is essential when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. Elderly people or those in poor health and patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures) should consult their doctor before using the medicine. Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe systemic absorption of sodium phosphate rectal solution is limited, however in some conditions it may be increased and predispose to possible interactions with other drugs. The simultaneous intake of drugs that can have effects on electrolyte balance (such as diuretics, cortisone, calcium channel blockers, lithium) can facilitate the onset of hyperphosphatemia, hypercalcemia and hypernatremia. Patients taking drugs that can prolong the QT interval may be at greater risk of developing this adverse reaction if treated concomitantly with sodium phosphate. Since hypernatremia is associated with low lithium levels, the concomitant use of Enema lax and lithium may cause a reduction in serum lithium levels, with a decrease in efficacy. Concomitant use of calcium supplements or calcium-containing antacids may increase the risk of ectopic calcification. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of sodium phosphate organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eImmune system disorders\u003c\/i\u003e Hypersensitivity reactions (e.g. urticaria) \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Blisters, itching, burning \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation. Nausea, vomiting. \u003ci\u003eMetabolism and nutrition disorders\u003c\/i\u003e Hyperphosphatemia, hypokalemia, hypernatremia, hypocalcemia, and tissue calcification may rarely occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe effect most frequently observed following ingestion or rectal administration is gastrointestinal irritation (abdominal pain, nausea, vomiting, diarrhoea). Persistent diarrhea results in loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Fluid and electrolyte losses must be replaced. Generally, conservative measures are sufficient; plenty of liquids must be given, especially fruit juices. See also what is reported in paragraph 4.4 regarding the abuse of laxatives. If a significant amount of phosphate is absorbed, hyperphosphatemia, hypocalcemia, and hypomagnesemia may occur. Alterations in fluid and electrolyte balance have been observed following oral, rectal and intravenous exposure. Severe hyperphosphatemia and hypocalcemia may cause tetany, convulsions, bradycardia, QT interval prolongation, arrhythmia, coma and cardiac arrest. Severe dehydration, hypernatremia, hypotension, metabolic acidosis, and tachycardia may also occur. The elderly, children and patients with renal insufficiency are at increased risk of toxic effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131295793479,"sku":"024995033","price":5.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-clisma-lax-soluzione-rettale-133ml-farmacia-dottor-tili-1213792210.jpg?v=1767134489"},{"product_id":"melilax-pediatric-6-microclismi","title":"Melilax Pediatric 6 microenemas","description":"\u003cp\u003eThe \u003cstrong\u003eMelilax Pediatric 6 microenemas\u003c\/strong\u003e is a class IIb medical device, specially formulated to offer a delicate evacuating action and a protective and soothing action on the rectal mucosa. This product is particularly suitable for the treatment of \u003cstrong\u003econstipation\u003c\/strong\u003e in children and infants, ensuring effective relief from the discomfort, irritation and inflammation associated with this condition.\u003c\/p\u003e\n\n\u003cp\u003eIts effectiveness is due to \u003cstrong\u003ePROMELAXIN\u003c\/strong\u003e, an active complex of nectar and honeydew honeys, enriched with polysaccharides derived from \u003cstrong\u003eAloe and Mallow\u003c\/strong\u003e. This unique combination allows Melilax to stimulate physiological and balanced evacuation, without irritating the rectal mucosa. Furthermore, thanks to its mucous-like properties and its viscosity, the product protects the mucosa during the passage of feces, mimicking the lubricating action of physiological mucus.\u003c\/p\u003e\n\n\u003cp\u003eThe \u003cstrong\u003eMelilax Pediatric\u003c\/strong\u003e it is also ideal in conditions such as \u003cstrong\u003evisceral hypersensitivity\u003c\/strong\u003e, irritable colon, fissures and hemorrhoids, thanks to its indirect anti-inflammatory action and antioxidant properties. This microenema is gluten-free, making it also suitable for those with food intolerances.\u003c\/p\u003e\n\n\u003cp\u003eWith the \u003cstrong\u003eMelilax Pediatric 6 microenemas\u003c\/strong\u003e, parents can count on a safe and effective product to relieve constipation in children, guaranteeing a delicate and respectful action on the intestinal physiology of children and infants.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Melilax Pediatric 6 microenemas used? What is it for?\u003c\/h3\u003e\u003cp\u003eThe \u003cstrong\u003eMelilax Pediatric 6 microenemas\u003c\/strong\u003e is a class IIb medical device, specially formulated to offer a delicate evacuating action and a protective and soothing action on the rectal mucosa. This product is particularly suitable for the treatment of \u003cstrong\u003econstipation\u003c\/strong\u003e in children and infants, ensuring effective relief from the discomfort, irritation and inflammation associated with this condition.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Melilax Pediatric 6 microenemas contain?\u003c\/h3\u003e\u003cp\u003ePromelaxin complex of honey and polysaccharides from aloe and mallow\u003cbr\u003eTitle in: monosaccharides ≥ 50%, polysaccharides (Molecular Weight \u003e 20,000 Daltons) ≥ 0.3%.\u003cbr\u003eIt also contains: hydroglycerine mixture; Lemon juice; Lavender essential oil.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Melilax Pediatric 6 microenemas?\u003c\/h3\u003e\u003cp\u003e• Children aged 3-12 years: 1 microenema of 5 g as needed. In case of stubborn constipation, apply 2 doses consecutively.\u003cbr\u003e• Children from 1-3 years: 1 microenema of 5 g as needed.\u003cbr\u003e• Infants from 0-1 year: half microenema of 5 g as needed.\u003c\/p\u003e\u003cp\u003eOpen the microenema by removing the safety cannula cover:\u003cbr\u003e- grasp the white round ring located above the bellows;\u003cbr\u003e- with the other hand bend the cannula cover until it breaks and completely detaches from the ring nut;\u003cbr\u003e- remove the cannula cover.\u003cbr\u003eTo facilitate the application of the microenema, it is preferable to position the child on his left side with his knees bent towards his abdomen.\u003cbr\u003eApply a few drops of product to the perianal area and gently introduce the cannula into the rectum. Press the microenema thoroughly and at the end of the application keep it pressed until the cannula is completely extracted, to prevent the product from being re-aspirated.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Melilax Pediatric 6 microenemas?\u003c\/h3\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eIn case of persistent constipation it is important to consult your doctor to rule out other pathologies.\u003cbr\u003eThe microenema is disposable, therefore it must not be reused if half a dose is administered, as in the case of infants.\u003cbr\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Melilax Pediatric 6 microenemas stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature, away from heat sources and protected from light.\u003cbr\u003eThe expiry date refers to the intact and correctly stored product. Do not use after the indicated expiry date.\u003cbr\u003eValidity with intact packaging: 30 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Melilax Pediatric 6 microenemas?\u003c\/h3\u003e\u003cp\u003e6 disposable microenemas with cannula cover for children and infants of 5 g each.\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":51131300544839,"sku":"932501416","price":11.31,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aboca-spa-societa-agricola-melilax-pediatric-6-microclismi-farmacia-dottor-tili-1213792188.jpg?v=1767127270"},{"product_id":"dulcolax-adulti-10mg-6-supposte","title":"Dulcolax adults 10mg 6 suppositories","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS One coated tablet contains: bisacodyl 5 mg. Excipients with known effects: lactose, sucrose, castor oil. ADULTS SUPPOSITORIES One suppository contains: bisacodyl 10 mg. CHILDREN SUPPOSITORIES One suppository contains: bisacodyl 5 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS \u003cb\u003eLactose\u003c\/b\u003e \u003cb\u003emonohydrate\u003c\/b\u003e, corn starch, modified starch, glycerol, magnesium stearate, \u003cb\u003esucrose\u003c\/b\u003e, talc, gum arabic, titanium dioxide (E171), methacrylic acid\/methyl methacrylate copolymer (1:1), methacrylic acid\/methyl methacrylate copolymer (1:2), \u003cb\u003ecastor oil\u003c\/b\u003e, macrogol 6000, iron oxide (E172), white wax, carnauba wax, shellac. SUPPOSITORIES Triglycerides of saturated fatty acids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients. Dulcolax is also contraindicated in patients with paralytic ileus, acute abdominal conditions, such as appendicitis, and severe abdominal pain associated with nausea and vomiting which may be signs indicative of serious pathological conditions, in intestinal obstruction or stenosis, acute inflammation of the gastrointestinal tract, rectal bleeding of unknown origin, severe state of dehydration. Pregnancy and breastfeeding (see section 4.6). The use of Dulcolax is contraindicated in cases of rare hereditary conditions that may be incompatible with the intake of one of the excipients (see section 4.4 \"special warnings and precautions for use\"). Dulcolax is contraindicated in children under 2 years of age. Suppositories are contraindicated in cases of anal fissures and ulcers (perianal pain and bleeding may occur).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCOATED TABLETS - Adults: 1-2 coated tablets per day. \u003cu\u003ePediatric population\u003c\/u\u003e \u003ci\u003e - \u003c\/i\u003eChildren over 10 years: 1-2 coated tablets per day. - Children aged between 2 and 10 years: 1 coated tablet per day. It is advisable to start with the minimum expected dose. The dose can then be increased, up to the maximum recommended dose, for regular stool evacuation. The maximum daily dose must never be exceeded. \u003cu\u003eInstructions for use\u003c\/u\u003e Take the coated tablets preferably in the evening to determine an evacuation the following morning (after approximately 10 hours). When administered in the morning, on an empty stomach, the effect is obtained after approximately five hours. The coated tablets should not be administered together with products that reduce the acidity of the upper gastrointestinal tract, such as milk, antacids (e.g. bicarbonate) or proton pump inhibitors. The coated tablets should be swallowed whole. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine. SUPPOSITORIES - Adults: 1 adult suppository (10 mg) per day. \u003cu\u003ePediatric population\u003c\/u\u003e - Children over 10 years: 1 adult suppository (10 mg) per day. - Children aged between 2 and 10 years: 1 children's suppository (5 mg) per day. The maximum daily dose must never be exceeded. Children aged 10 years and younger with chronic or persistent constipation should take Dulcolax under their doctor's supervision. Dulcolax must not be administered to children under two years of age. \u003cu\u003eInstructions for use\u003c\/u\u003e The effect of suppositories usually occurs in about 20 minutes (range: 10 - 30 minutes). Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCoated tablets: this medicine does not require any special storage conditions. Suppositories: Do not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings\u003c\/u\u003e Like all laxatives, Dulcolax should not be taken continuously every day or for long periods of time without investigating the cause of the constipation. In case of diabetes mellitus, hypertension or heart disease, use only after consulting your doctor. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Intestinal loss of fluids can cause dehydration. Symptoms may be thirst and oliguria. In patients for whom dehydration may be dangerous (patients with renal insufficiency, elderly patients), treatment with Dulcolax should be stopped and restarted only under medical supervision. Hematochezia (blood in the stool) may occur in patients, which is usually mild and goes away on its own. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Cases of dizziness and\/or syncope have been reported after taking Dulcolax. The data relating to these cases suggest that the events, rather than a phenomenon related to the intake of Dulcolax, could be interpreted as a manifestation of \"defecation syncope\" (attributable to the effort of the act of defecation), or as a vasovagal response to abdominal pain related to the constipation itself. The use of suppositories can lead to painful sensations and local irritation, in particular, in patients with fissures and ulcerative proctitis (see section 4.3 “contraindications”). Stimulant laxatives including Dulcolax do not contribute to weight loss (see section 5.1 “Pharmacodynamic properties”). \u003cb\u003eImportant information about some excipients:\u003c\/b\u003e Dulcolax tablets contain 33.2 mg of \u003cu\u003elactose\u003c\/u\u003e equal to 66.42 mg in case of taking the maximum daily dose, for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine tablets. Dulcolax tablets contain 23.4 mg of \u003cu\u003esucrose\u003c\/u\u003e equal to 46.8 mg when taking the maximum daily dose for the treatment of constipation in adults and adolescents over 10 years of age. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency should not take this medicine tablets. Dulcolax tablets may cause gastric upset and diarrhoea. \u003cu\u003ePrecautions for use\u003c\/u\u003e In children aged between 2 years and 10 years the medicine can only be used after consulting the doctor (see section 4.3). Like all laxatives, it should not be taken daily or for prolonged periods without first evaluating the cause of the constipation. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant administration of diuretics or adrenocorticosteroids and excessive doses of Dulcolax may lead to an increased risk of electrolyte imbalance. This imbalance, in turn, can lead to increased sensitivity to cardiac glycosides. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least two hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of other laxatives may potentiate the gastrointestinal side effects of Dulcolax.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe most commonly reported side effects during treatment with Dulcolax are abdominal pain and diarrhea. \u003cu\u003eImmune system disorders\u003c\/u\u003e: anaphylactic reactions, angioneurotic edema as well as other hypersensitivity reactions. \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e: dehydration. \u003cu\u003eNervous system disorders\u003c\/u\u003e: dizziness, syncope. The phenomena of dizziness and syncope that occur after taking bisacodyl appear to be attributable to a vasovagal response (resulting, for example, from abdominal pain, or the evacuation of feces). \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e: abdominal cramps, abdominal pain, diarrhea, nausea, hematochezia (blood in stool), vomiting, abdominal discomfort, anorectal discomfort, colitis including ischemic colitis. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e \u003cu\u003eReporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: \u003c\/u\u003e \u003cu\u003ehttp:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetta-reazione-avversa.\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e Excessive doses can cause abdominal pain and diarrhea, and significant losses of potassium and other electrolytes. Chronic overdose of Dulcolax, as with other laxatives, can cause chronic diarrhea, abdominal pain, hypokalemia, secondary hyperaldosteronism and kidney stones. Renal tubular injury, metabolic alkalosis, and muscle weakness secondary to hypokalemia have also been described in association with chronic laxative abuse. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives. \u003cu\u003eTreatment\u003c\/u\u003e If action is taken within a short time of ingesting the oral form of Dulcolax, absorption can be reduced or avoided by inducing vomiting or gastric lavage. Fluid and electrolyte losses must be replaced. This is especially important in elderly and young patients. The administration of spasmolytics may be useful.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate and well-controlled studies on the use of the medicine during pregnancy. Therefore, although unwanted or toxic effects have never been reported during pregnancy, like all medicines, Dulcolax must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. \u003cu\u003eFertility\u003c\/u\u003e No studies have been conducted to investigate the effects on human fertility. \u003cu\u003eBreastfeeding\u003c\/u\u003e Clinical data demonstrate that neither the active form of bisacodyl BHPM, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), nor its glucuronic derivatives are excreted in breast milk, however the medicine should only be used if necessary, under direct medical supervision, after evaluating the expected benefit for the mother in relation to the possible risk for the infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies on the effects on the ability to drive and use machines have been performed. However, patients should be informed that due to vasovagal response (e.g., abdominal spasm), dizziness and\/or syncope may occur. If patients experience abdominal spasm they should avoid potentially dangerous activities such as driving or using machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131302641991,"sku":"008997025","price":8.46,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-dulcolax-adulti-10mg-6-supposte-farmacia-dottor-tili-1213792177.jpg?v=1767134627"},{"product_id":"melilax-adulti-6-microclismi","title":"Melilax Adults 6 micro enemas","description":"\u003cp\u003eThe \u003cstrong\u003eMelilax Adults 6 microenemas\u003c\/strong\u003e is a class IIb medical device, designed to offer an effective solution to constipation, combining an evacuating action with a protective and soothing action on the rectal mucosa. This microenema is formulated based on honey, taking advantage of the active complex \u003cstrong\u003ePROMELAXIN\u003c\/strong\u003e, which includes nectar and honeydew honeys selected for their content of monosaccharides, polysaccharides and melanoidins, enriched with polysaccharides from \u003cstrong\u003eAloe and Mallow\u003c\/strong\u003e. \u003c\/p\u003e\n\n\u003cp\u003eThanks to its composition, Melilax Adulti guarantees a non-irritating evacuating action, stimulating a physiological and balanced activation of defecation. Its mucous-like properties and viscosity protect the rectal mucosa during the passage of feces, mimicking the lubricating action of physiological mucus. Furthermore, the antioxidant action of the product helps to protect and soothe the mucosa, offering an indirect anti-inflammatory action. \u003c\/p\u003e\n\n\u003cp\u003eIndicated for the treatment of constipation, the \u003cstrong\u003eMelilax Adults\u003c\/strong\u003e it is particularly useful in the presence of visceral hypersensitivity, as in the case of irritable bowel syndrome, fissures and hemorrhoids. It is also suitable for use during pregnancy and breastfeeding, making it a versatile choice for adults and children aged 12 and over. Furthermore, the product is \u003cstrong\u003egluten free\u003c\/strong\u003e, guaranteeing safety even for those with food intolerances. \u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Melilax Adults 6 microenemas used? What is it for?\u003c\/h3\u003e\u003cp\u003eMicroenema medical device based on honey (PROMELAXIN complex) with aloe and mallow, indicated for the treatment of constipation; promotes a non-irritating evacuating action and protects and soothes the rectal mucosa during the passage of feces.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Melilax Adults 6 microenemas contain?\u003c\/h3\u003e\u003cp\u003ePromelaxin complex of honey and polysaccharides from aloe and mallow\u003cbr\u003eTitle in: monosaccharides ≥ 50%, polysaccharides (Molecular Weight \u003e 20,000 Daltons) ≥ 0.3%.\u003cbr\u003eIt also contains: hydroglycerine mixture; Lemon juice; Lavender essential oil.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Melilax Adults 6 microenemas?\u003c\/h3\u003e\u003cp\u003e1 10 g microenema as needed.\u003cbr\u003eIn case of stubborn constipation, apply 2 doses consecutively.\u003c\/p\u003e\u003cp\u003eOpen the microenema by removing the safety cannula cover:\u003cbr\u003e- grasp the white round ring located above the bellows;\u003cbr\u003e- with the other hand bend the cannula cover until it breaks and completely detaches from the ring nut;\u003cbr\u003e- remove the cannula cover.\u003cbr\u003eApply a few drops of product to the perianal area and gently introduce the cannula into the rectum. Press the microenema thoroughly and at the end of the application keep it pressed until the cannula is completely extracted, to prevent the product from being re-aspirated.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Melilax Adults 6 microenemas?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eIn case of persistent constipation it is important to consult your doctor to rule out other pathologies.\u003cbr\u003eThe microenema is disposable, therefore it must not be reused if half a dose is administered, as in the case of infants.\u003cbr\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Melilax Adults 6 microenemas not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Melilax Adults 6 microenemas stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature, away from heat sources and protected from light.\u003cbr\u003eThe expiry date refers to the intact and correctly stored product. Do not use after the indicated expiry date.\u003cbr\u003eValidity with intact packaging: 30 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Melilax Adults 6 microenemas?\u003c\/h3\u003e\u003cp\u003e6 disposable microenemas with cannula cover for adults and children, 10 g each.\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":51131344847175,"sku":"932501392","price":11.31,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aboca-spa-societa-agricola-melilax-adulti-6-microclismi-farmacia-dottor-tili-1213791970.jpg?v=1767149430"},{"product_id":"guttalax-7-5mg-ml-gocce-orali-15ml","title":"Guttalax 7.5mg\/ml oral drops 15ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 ml (15 drops) of solution contains: Active ingredient: sodium picosulphate 7.5 mg. Excipient with known effects: Sorbitol (E420) 450 mg (see section 4.4). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium benzoate, liquid sorbitol (E420), sodium citrate, citric acid monohydrate, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGuttalax is contraindicated in patients with: • Hypersensitivity to the active substance and to any excipients, listed in paragraph 6.1; • Paralytic ileus or intestinal or biliary tract obstruction or stenosis; • Acute severe painful and\/or febrile abdominal conditions (such as appendicitis) associated with nausea and vomiting; • Severe state of dehydration; • Rare hereditary conditions of incompatibility with one of the excipients (see section 4.4). • Nausea or vomiting; • Acute inflammation of the gastrointestinal tract; • Rectal bleeding of unknown origin; • Gallstones; • Liver failure; • Pregnancy and breastfeeding (see section 4.6). Do not administer to children under 3 years of age (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following dosages are recommended: \u003cu\u003eAdults\u003c\/u\u003e In adults it is recommended to start with 7-8 drops in water per day and to decrease if the effect is excessive or to increase if the laxative effect is not achieved. In cases of stubborn constipation, up to 15-20 drops in water can be used. \u003cu\u003ePediatric population\u003c\/u\u003e In children (over 3 years): 2-3 drops in water per day. Do not exceed the recommended doses. It is advisable to initially use the minimum doses provided. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Guttalax should preferably be taken in the evening to induce evacuation the following morning. Swallow together with an adequate amount of water. A diet rich in liquids favors the effect of the medicine. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eKeep the bottle in the outer carton in order to protect the medicine from light. Validity after first opening: 12 months.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eWarnings\u003c\/u\u003e Like all laxatives, Guttalax should not be taken continuously every day or for long periods of time without investigating the cause of constipation. Prolonged and excessive use can lead to diarrhea, electrolyte imbalance and hypokalemia. Cases of dizziness and\/or syncope have been reported in patients taking Guttalax. The data available on these cases suggest that the events could be related to syncope from defecation (or syncope attributable to the effort of evacuation), or to a vasovagal response to abdominal pain related to constipation, and not necessarily to the intake of sodium picosulfate itself. The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). \u003cu\u003ePrecautions for use\u003c\/u\u003e In children aged between 3 and 12 years the medicine can only be used after consulting the doctor. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. This medicinal product contains 450 mg of sorbitol in 1 ml (15 drops), equivalent to 600 mg of sorbitol in the maximum recommended daily dose of 1.33 ml (20 drops) in the treatment of an adult patient. Sorbitol is a source of fructose. Patients with hereditary fructose intolerance (HFI), a rare genetic disease, should not be given this medicine. This medicinal product contains less than 1 mmol sodium (23 mg) in 20 drops, the maximum recommended daily dose for an adult, i.e. it is essentially “sodium-free”.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Continued use of Guttalax may increase patients' response to oral anticoagulants and change glucose tolerance. The concomitant use of diuretics or adrenocorticosteroids and excessive doses of Guttalax may lead to an increased risk of electrolyte imbalance. This imbalance, in turn, can lead to increased sensitivity to cardiac glycosides. Concomitant administration of antibiotics may reduce the laxative effect of Guttalax.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLike all medicines, Guttalax can cause side effects, although not everybody gets them. Adverse reactions are listed below by system organ class and frequency, according to the following categories: Very common ≥ 1\/10 Common ≥ 1\/100, \u003c 1\/10 Uncommon ≥ 1\/1,000, \u003c 1\/100 Rare ≥ 1\/10,000, \u003c 1\/1,000 Very rare \u003c 1\/10,000 Not known frequency cannot be defined on the basis of available data. \u003cu\u003eImmune system disorders\u003c\/u\u003e. Not known*: hypersensitivity. \u003cu\u003eNervous system disorders\u003c\/u\u003e. Uncommon: dizziness; Not known*: syncope. The phenomena of dizziness and syncope that occur after taking sodium picosulphate appear to be attributable to a vasovagal response (resulting, for example, from abdominal pain or the evacuation of feces). \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e. Very common: diarrhea; Common: abdominal cramps, abdominal pain and abdominal discomfort; Uncommon: vomiting, nausea. Occasionally: isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. \u003cu\u003ePathologies of the skin and subcutaneous tissue\u003c\/u\u003e. Not known*: skin reactions such as angioedema, rash on taking the medicine, rash, itching. \u003ci\u003e*These adverse reactions were observed in post-marketing experience. At 95% probability, the frequency category is not greater than uncommon, but could be lower. A precise estimate of the frequency is not possible since these adverse reactions did not occur in 1020 patients in clinical trials\u003c\/i\u003e. \u003cu\u003eReporting of side effects\u003c\/u\u003e If you get any side effects, including any not listed in this leaflet, contact your doctor or pharmacist. Undesirable effects can also be reported directly via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse. Reporting side effects helps provide more information on the safety of this medicine\u003ci\u003e.\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSigns and symptoms\u003c\/u\u003e Following the intake of high doses of the drug, the following may occur: watery stools (diarrhoea), abdominal cramps and a significant loss of fluids, potassium and other electrolytes. Cases of colonic mucosal ischemia have been reported with doses of Guttalax considerably higher than the recommended dosage for the treatment of occasional constipation. Guttalax, like other laxatives, in case of overdose causes chronic diarrhea, abdominal pain, hypokalemia, secondary hyperaldosteronism and kidney stones. In association with chronic laxative abuse, renal tubular injury, metabolic alkalosis and muscle weakness secondary to hypokalemia have also been described. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives. \u003cu\u003eTreatment\u003c\/u\u003e If action is taken within a short time of ingesting Guttalax, absorption can be reduced or avoided by inducing vomiting or gastric lavage. Fluid and electrolyte losses must be replaced. This is especially important in the elderly and young people. The administration of spasmolytics may be useful.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eFertility\u003c\/u\u003e No studies have been conducted to evaluate the effects on human fertility. Non-clinical studies have revealed no effects on fertility (see section 5.3). \u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate and well-controlled studies on the use of the medicine during pregnancy. Long experience has shown no evidence of unwanted or harmful effects during pregnancy. Although toxic effects have never been reported during pregnancy, the medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. \u003cu\u003eBreastfeeding\u003c\/u\u003e Clinical data demonstrate that neither the active fraction of sodium picosulphate, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), nor the conjugated form (its glucuronic derivatives), are excreted in measurable quantities in breast milk. However, the medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince no specific studies have been carried out, there are no known inhibitory effects of Guttalax that would compromise the ability to drive and use machinery. However, patients should be informed that due to vasovagal response (e.g., abdominal spasm), dizziness and\/or syncope may occur. If patients experience abdominal spasm they should avoid potentially dangerous activities such as driving or using machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131350286663,"sku":"020949020","price":10.36,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-guttalax-7-5mg-ml-gocce-orali-15ml-farmacia-dottor-tili-1213791960.jpg?v=1767149908"},{"product_id":"alaxa-5mg-20-compresse-gastroresistenti","title":"Alaxa 5mg 20 gastro-resistant tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach gastro-resistant tablet contains: Active ingredient: bisacodyl 5 mg; Excipients with known effects: lactose monohydrate, sucrose, carboxymethylcellulose \u003cb\u003esodium\u003c\/b\u003e. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eTablet core\u003c\/i\u003e: \u003cb\u003elactose monohydrate\u003c\/b\u003e, corn starch, magnesium stearate, gelatin. \u003ci\u003eGastro-resistant film-coating\u003c\/i\u003e: diethyl phthalate, cellulose acetophthalate, talc. \u003ci\u003eSugary coating\u003c\/i\u003e: acacia, \u003cb\u003esucrose\u003c\/b\u003e, carboxymethylcellulose\u003cb\u003e sodium\u003c\/b\u003e, macrogol 6000, titanium dioxide, calcium carbonate, talc.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to other chemically related substances or to any of the excipients listed in paragraph 6.1. - Children under 3 years of age. - Generally contraindicated during pregnancy and breastfeeding (see section 4.6). - Subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration, acute surgical abdomen, appendicitis, gastroenteritis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e: 2 tablets per day; in particularly stubborn cases, 3 tablets. \u003ci\u003ePediatric population\u003c\/i\u003e. \u003cu\u003eChildren aged between 3 and 12 years\u003c\/u\u003e: 1-2 tablets per day (0.3 mg\/kg) under direct medical supervision. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. \u003cu\u003eMethod of administration\u003c\/u\u003e: The tablets should be swallowed whole, without chewing, together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine. The tablets should preferably be administered after the evening meal, so that the effect of the laxative, which occurs after 10-12 hours, does not disturb sleep. If taken on an empty stomach, the laxative effect occurs within approximately 5 hours. Take ALAXA at ​​least 1 hour after taking milk or antacids and at least two hours after taking other medicines orally.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine does not require any particular storage temperature. Store in the original packaging, to protect the medicine from moisture.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAbuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Furthermore, the abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and therefore the possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Frequent or prolonged use of the medicine must be avoided as it can cause addiction and atonic colitis. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Caution is recommended if the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks; when rectal bleeding is present; when the use of the laxative fails to produce effects or when the patient suffers from diabetes mellitus, hypertension or heart disease. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. \u003ci\u003ePediatric population\u003c\/i\u003e: In children under 12 years of age the medicine can only be used after consulting a doctor. \u003cu\u003eImportant information about some excipients:\u003c\/u\u003e ALAXA contains: - lactose monohydrate: patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine; - sucrose: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. - sodium: This medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMilk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of diuretics, cardiac glycosides or adrenocorticosteroids may promote electrolyte imbalance. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOccasionally: isolated cramping pain or abdominal colic. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced. Muscle weakness and weight loss may occur. In case of accidental overdose, gastric lavage is indicated. See also what is reported in paragraph 4.4 regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore, the medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no limitations. However, those carrying out an activity that requires vigilance should use caution.\u003c\/p\u003e","brand":"Angelini Acraf","offers":[{"title":"Default Title","offer_id":51131368341831,"sku":"009262015","price":7.51,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-a-c-r-a-f-spa-alaxa-5mg-20-compresse-gastroresistenti-farmacia-dottor-tili-1213791893.jpg?v=1767150208"},{"product_id":"tamarine-8-0-39-marmellata-vasetto-260g","title":"Tamarine 8% + 0.39% jam jar 260g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of product contains: \u003cb\u003eActive ingredients:\u003c\/b\u003e Cassia Angustifolia 8 g - Cassia fistula 0.39 g. \u003cu\u003eExcipients with known effects\u003c\/u\u003e: sucrose, sodium methyl parahydroxybenzoate, sodium hydroxide For the complete list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTamarindus indica soft extract, coriandrum sativum powder, glycyrrhiza glabra dry extract, sodium methyl parahydroxybenzoate, mirabella essence, sodium hydroxide (for pH adjustment), citric acid (for flavor adjustment), jam (sucrose, fruit, tartaric acid, potassium sorbate, water).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes. Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. Laxatives are contraindicated in subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Children under 10 years old. Pregnancy and breastfeeding (see p. 4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to use the minimum doses initially. When necessary, the dose can then be increased, but without ever exceeding the indicated one. Take preferably in the evening. \u003cb\u003eAdults: \u003c\/b\u003e1 teaspoon. \u003cb\u003eChildren over 10 years old\u003c\/b\u003e: ¼ teaspoon. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C. Keep container tightly closed. For storage conditions after first opening, see paragraph 6.3.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eWarnings\u003c\/u\u003e \u003c\/b\u003e Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). \u003cb\u003e \u003cu\u003ePrecautions for use \u003c\/u\u003e \u003c\/b\u003e The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. \u003cb\u003eTamarine contains sucrose.\u003c\/b\u003e Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine \u003cb\u003eTamarine contains sodium methyl parahydroxybenzoate.\u003c\/b\u003e May cause allergic reactions (even delayed). \u003cb\u003eTamarine contains less than 1 mmol (23 mg) sodium per serving (1 teaspoon)\u003c\/b\u003e, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. Concomitant use of other drugs that induce hypokalemia (e.g. diuretics, adrenocorticosteroids and licorice) may increase electrolyte imbalance. Hypokalemia (resulting from abuse of laxatives taken for a long time) enhances the action of cardiac glycosides and interferes with antiarrhythmic drugs, with other drugs that induce the return to sinus rhythm (quinidine) and with drugs that induce prolongation of the Q-T interval.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine may occasionally cause: isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. With the use of this medicine, the urine sometimes turns slightly yellow-brown or red. This coloring is simply due to the presence of senna components in the urine and is not clinically significant. Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as: very common (≥ 1\/10), common (≥ 1\/100, \u003c 1\/10); uncommon (≥ 1\/1,000, \u003c 1\/100); rare (≥ 1\/10,000; \u003c 1\/1,000); very rare (\u003c 1\/10,000), or not known (frequency cannot be estimated from the available data). \u003cb\u003eTable 4-1 Undesirable effects in the post-marketing experience\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eImmune system disorders (not known) - Adverse event: Hypersensitivity reactions\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders (not known) - Adverse event: Hyperaldosteronism, Hypocalcemia, Hypomagnesemia, Dehydration, Hypokalemia, Hyponatremia, Decreased blood electrolytes.\u003c\/p\u003e\n\u003cp\u003eVascular disorders (not known) - Adverse event: Hypotension.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders (not known) - Adverse event: Megacolon, Diarrhea, Nausea, Abdominal discomfort.\u003c\/p\u003e\n\u003cp\u003eMusculoskeletal system and connective tissue disorders (not known) - Adverse event: Myopathy.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders (not known) - Adverse event: Kidney problems, Chromaturia.\u003c\/p\u003e\n\u003cp\u003eSystemic disorders and conditions relating to the site of administration (not known) - Adverse event: Fatigue, Tolerance to the drug (see Warnings and Precautions for use).\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced with fluid intake. Treatment: discontinuation of the drug. Also see what is reported in the paragraph “Special warnings and precautions for use” regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore, since anthraquinone laxatives may be excreted in breast milk, breastfeeding mothers should avoid taking Tamarine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known effects on the ability to drive and use machines.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51131368407367,"sku":"021528157","price":18.76,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-tamarine-8-0-39-marmellata-vasetto-260g-farmacia-dottor-tili-1213791898.jpg?v=1767150189"},{"product_id":"regolint-9-7-g-20-bustine-polvere-per-soluzione-orale","title":"Regolint 9.7 g 20 sachets powder for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eOne sachet contains\u003c\/u\u003e: \u003cu\u003eActive ingredient\u003c\/u\u003e: macrogol 4000 g 9,736. For the complete list of excipients see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAcesulfame potassium, banana flavour.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to macrogol (polyethylene glycol) or to any of the excipients; severe inflammatory bowel disease (such as ulcerative colitis, Crohn's disease) or toxic megacolon, associated with symptomatic stricture; perforation or risk of perforation of the digestive tract; ileus or suspected intestinal obstruction; acute abdominal pain or pain of unknown origin; nausea or vomiting, marked accentuation or reduction of peristalsis, rectal bleeding; severe state of dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eAdults and children over 8 years of age and weighing over 20 kg\u003c\/i\u003e The daily dose must be adapted based on the clinical effect obtained and can vary from one sachet every other day (especially in children) up to 2 sachets per day. Do not exceed the maximum daily dosage of 20 g of macrogol. The indicated dose should be adjusted based on individual response. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. The daily dose can be taken in one or two fractions, between meals. If you need to take a sachet, it must be taken in the morning. If you need to take multiple sachets, you will need to divide the doses between morning and evening. The effect of REGOLINT manifests itself in the 24-48 hours following its administration. Sometimes it can take two days (or more) before you get the desired effect. In this case, continue the treatment keeping in mind, however, that laxatives must be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. In children, in the absence of clinical data on administration periods exceeding three months, treatment should not exceed three months. Dissolve the contents of one sachet in at least 125 ml (equal to a glass) of water. Do not add other ingredients. It is preferable to drink the entire quantity quite quickly (within a few minutes) avoiding sipping it for a long time. A diet rich in liquids favors the effect of the medicine. The regularization of intestinal motility induced by the treatment must be maintained with a healthy lifestyle and correct nutrition.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original package to protect the medicine from moisture.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eWarnings\u003c\/i\u003e \u003c\/b\u003e Efficacy data in children under 2 years of age are limited. The treatment of constipation with any medicine is only an adjunct to a healthy lifestyle and correct nutrition, for example: increased intake of liquids and vegetable fibres, appropriate physical activity and restoration of intestinal motility. Before starting treatment, organic diseases must be excluded. Laxatives should not be used by subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, marked accentuation or reduction of peristalsis, rectal bleeding. The presence of one or more of these symptoms or signs requires an adequate diagnostic investigation by the doctor in order to exclude one of the pathological conditions that contraindicate the use of laxatives (for example: obstruction or suspected intestinal obstruction, intestinal stenosis or perforation, paralytic ileus, serious inflammatory diseases of the intestine). After a 3-month course of treatment, full clinical supervision of constipation should be performed. The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Caution should be exercised in the elderly, in patients with hepatic insufficiency, renal insufficiency, heart failure. In these cases it is advisable to periodically check serum electrolyte levels. The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). REGOLINT, not containing any sugar or polyol, can be taken by diabetic patients or those undergoing a galactose-free regime. \u003cb\u003e \u003ci\u003ePrecautions for use\u003c\/i\u003e \u003c\/b\u003e In children the medicine can only be used after consulting a doctor. The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. Consult your doctor when the need for the laxative arises from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. It is also advisable for elderly people or those in poor health to consult their doctor before using the medicine. Very rare cases of hypersensitivity reactions (rash, urticaria, edema) have been reported with some macrogol-containing medicinal products, including exceptional cases of anaphylactic shock. In these cases, stop taking the medicine and consult a doctor immediately.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine and therefore the absorption of other drugs administered simultaneously orally. Therefore, avoid ingesting laxatives and other drugs at the same time: after taking a medicine, leave an interval of at least two hours before taking the laxative. Caution should be used when Regolint is used with drugs with a narrow therapeutic index (e.g. antiepileptics and immunosuppressive agents). The use of licorice increases the risk of hypokalemia.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdverse drug reactions are listed by frequency using the following frequency classes: very common (≥ 1\/10), common (≥ 1\/100, \u003c 1\/10), uncommon (≥1\/1,000, \u003c1\/100), rare (≥1\/10,000, \u003c1\/1,000), very rare (\u003c1\/10,000) and not known (frequency cannot be estimated). based on available data). \u003cu\u003eAdults\u003c\/u\u003e: The side effects listed in the following table were reported during clinical trials involving 600 adult patients and from post-marketing data. The reported adverse reactions are usually mild in intensity and transient, and mainly affect the gastrointestinal system. In case of hypersensitivity reactions, stop taking the medicine and consult a doctor immediately.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Abdominal distension.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Nausea.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Vomiting.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Urgent evacuation.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Faecal incontinence.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Rectal irritation.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Electrolyte imbalance (hyponatremia, hypokalemia).\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Dehydration (particularly in the elderly).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare - Adverse reactions: Hypersensitivity reactions (pruritus, rash, urticaria, edema, face edema, angioedema, dyspnoea, anaphylactic shock).\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePediatric population\u003c\/u\u003e: The side effects listed in the table below were reported during clinical trials involving 147 children aged 6 months to 15 years, and from post-marketing data. As in the case of adults, the reported adverse reactions are usually mild in intensity and transient, and mainly affect the gastrointestinal system. In case of hypersensitivity reactions, stop taking the medicine and consult a doctor immediately.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Abdominal pain.\u003c\/p\u003e\n\u003cp\u003eCommon - Adverse reactions: Diarrhoea*.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Vomiting.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Abdominal distension.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Nausea.\u003c\/p\u003e\n\u003cp\u003eUncommon - Adverse reactions: Rectal irritation.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Hypersensitivity\u003c\/p\u003e\n\u003cp\u003e* Diarrhea can cause perianal pain \u003ci\u003eReporting of suspected adverse reactions\u003c\/i\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOverdose causes diarrhea which disappears with temporary interruption of treatment or reduction of the dose. Excessive fluid loss caused by diarrhea or vomiting may require correction of the electrolyte imbalance. Excessive doses can cause abdominal pain. Cases of aspiration have been reported during administration of large volumes of polyethylene glycol and electrolytes with a nasogastric tube. Children with neurological impairment who suffer from oromotor dysfunction are particularly at risk for aspiration. Also see what is reported in the paragraph \"Special warnings and precautions for use\" regarding the abuse of laxatives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies on the effects on the ability to drive and use machines have been performed.\u003c\/p\u003e","brand":"Baldacci","offers":[{"title":"Default Title","offer_id":51730202788167,"sku":"038204020","price":14.35,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/baldacci-regolint-9-7-g-20-bustine-polvere-per-soluzione-orale-farmacia-dottor-tili-1258975917.jpg?v=1789560579"},{"product_id":"casenlax-10-g-20-bustine-polvere-per-soluzione-orale","title":"Casenlax 10 g 20 sachets powder for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of constipation in adults and children aged 8 years and older. An organic disorder must be excluded before starting treatment. Casenlax must remain a temporary treatment adjuvant to an appropriate lifestyle and diet for constipation, with a maximum treatment cycle of 3 months in children. If symptoms persist despite associated dietary measures, a different underlying cause should be suspected and treated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach sachet contains 10 g of macrogol 4000. Excipients with known effects: 0.0000018 mg sulfur dioxide (E220) per sachet and less than 1 mmol (23 mg) sodium per sachet. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium saccharin (E954), apple flavour* *Composition of apple flavour: Natural flavour, maltodextrin, gum arabic E414, sulfur dioxide E220, alpha tocopherol E307.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. - Severe inflammatory bowel disease (such as ulcerative colitis, Crohn's disease) or toxic megacolon, associated with symptomatic stricture. - Perforation of the digestive system or risk of perforation of the digestive system. - Paralytic ileus or suspected intestinal obstruction. - Painful abdominal syndromes of an undetermined nature.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOral use \u003cu\u003eDosage\u003c\/u\u003e 1 to 2 sachets per day, preferably taken as a single dose in the morning. It is recommended to drink 125 ml of fluid (e.g. water) after each dose. The effect of Casenlax occurs within 24-48 hours after administration. The daily dose must be adapted according to the clinical effects and can vary from one sachet every other day (especially in children) up to 2 sachets per day. Treatment should be stopped gradually and restarted if constipation recurs. \u003ci\u003ePediatric population\u003c\/i\u003e 1 to 2 sachets per day, preferably taken as a single dose in the morning. It is recommended to drink 125 ml of fluid (e.g. water) after each dose. In children, treatment should not exceed 3 months due to the lack of clinical data in treatments lasting longer than 3 months. The regularization of intestinal motility induced by the treatment will be maintained by lifestyle and dietary measures. \u003cu\u003eMethod of administration\u003c\/u\u003e Each sachet should be dissolved in a glass of water (approximately 125 ml) just before use. The resulting solution will be clear and transparent like water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe treatment of constipation with any medicine is only an adjunct to a healthy lifestyle and diet, for example: - Increased intake of liquids and dietary fibre, - Adequate physical activity and re-education of intestinal motility. Due to the presence of sulfur dioxide Casenlax can rarely cause severe hypersensitivity reactions and bronchospasm. In case of diarrhoea, caution should be used in patients predisposed to water and\/or electrolyte balance disorders (e.g. elderly, patients with hepatic or renal impairment or patients being treated with diuretics) and electrolyte control should be considered. Hypersensitivity reactions (rash, urticaria and edema) have been reported with drugs containing macrogol (polyethylene glycol). Exceptional cases of anaphylactic shock have been reported. Casenlax contains a non-significant amount of sugars or polyols and can be prescribed to diabetic patients or patients following a galactose-free diet. This medicinal product contains less than 1 mmol (23 mg) sodium per sachet, i.e. essentially 'sodium-free'. Based on the mechanism of action of macrogol, fluid intake is recommended during treatment with this medicinal product (see section 5.1). The absorption of other medicinal products may be temporarily reduced due to the macrogol-induced increase in gastrointestinal transit rate (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere is a possibility that the absorption of other medicines may be temporarily reduced while using Casenlax. The therapeutic effect of medicinal products with a narrow therapeutic index (e.g. antiepileptics, digoxin and immunosuppressive agents) may be particularly affected.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects are listed by frequency using the following categories: Very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003cb\u003e \u003cu\u003eAdult population\u003c\/u\u003e:\u003c\/b\u003e The side effects listed in the following table were reported during clinical trials including 600 adult patients and in post-marketing experience. In general, adverse reactions were mild and transient and mainly affected the gastrointestinal system:\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Very rare - Adverse reactions: Hypersensitivity reactions (pruritus, rash, facial edema, Quincke's edema, urticaria, anaphylactic shock).\u003c\/p\u003e\n\u003cp\u003eSystem organs: Not known - Adverse reactions: Erythema.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders.\u003c\/p\u003e\n\u003cp\u003eSystem Organs: Not known - Adverse reactions: Electrolyte disturbances (hyponatremia, hypokalemia) and\/or dehydration, especially in elderly patients.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Common - Adverse reactions: Abdominal pain and\/or distension, Diarrhoea, Nausea.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Uncommon - Adverse reactions: Vomiting, Defecation urgency, Fecal incontinence.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003ePediatric population:\u003c\/u\u003e \u003c\/b\u003e The side effects listed in the following table were reported during clinical trials involving 147 children aged between 6 months and 15 years and in post-marketing use. As in the adult population, adverse reactions were generally mild and transient and mainly concerned the gastrointestinal system:\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Not known - Adverse reactions: Hypersensitivity reactions (anaphylactic shock, angioedema, urticaria, rash, pruritus).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Common - Adverse reactions: Abdominal pain, Diarrhoea*.\u003c\/p\u003e\n\u003cp\u003eSystem organs: Uncommon - Adverse reactions: Vomiting, Bloating, Nausea.\u003c\/p\u003e\n\u003cp\u003e* Diarrhea can cause perianal pain \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ehttp:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetta-reazione-avversa\u003c\/u\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOverdose can lead to diarrhea, abdominal pain and vomiting which disappear when treatment is stopped temporarily or the dosage is reduced. Excessive fluid loss due to diarrhea or vomiting may require correction of electrolyte imbalances. Cases of aspiration have been reported when large volumes of macrogol (polyethylene glycol) and electrolytes were administered via nasogastric tube. Neurologically compromised children who suffer from oromotor dysfunction are particularly at risk for aspiration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Animal studies do not indicate direct or indirect harmful effects of reproductive toxicity (see section 5.3). Data relating to the use of Casenlax in pregnant women are limited (less than 300 pregnancy outcomes). Casenlax is not expected to cause any effects during pregnancy, since systemic exposure to Casenlax is negligible. Casenlax can be used during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e There are no data on the excretion of Casenlax in breast milk. Macrogol 4000 is not expected to cause any effects on newborns\/infants, as systemic exposure to macrogol 4000 of breastfeeding women is negligible. Casenlax can be used during breastfeeding. \u003cu\u003eFertility\u003c\/u\u003e No fertility studies have been conducted with Casenlax; however, since macrogol 4000 is not significantly absorbed, no effects are expected.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCasenlax does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Casen Recordati","offers":[{"title":"Default Title","offer_id":51730205573447,"sku":"042583029","price":14.92,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/casen-recordati-casenlax-10-g-20-bustine-polvere-per-soluzione-orale-farmacia-dottor-tili-1254215771.jpg?v=1786736397"},{"product_id":"agiolax-granulato-400-g-confezione-con-cucchiaio-dosatore","title":"Agiolax granules 400 g pack with measuring spoon","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation in adults and adolescents over 12 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of granules contain \u003ci\u003eActive ingredients:\u003c\/i\u003e - Ispagula seed 52 g - Ispagula cuticle 2.2 g - Senna fruit 6.74 - 13.15 g equivalent to 300 mg of hydroxyanthracene derivatives calculated as sennoside B Excipients with known effects: sucrose For the complete list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTalc, gum arabic, cumin essence, sage essence, mint essence, liquid paraffin, solid paraffin, E 172, sucrose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• hypersensitivity to the active substances or to any of the excipients listed in section 6.1 • sudden irregularity of intestinal functions that persists for more than 2 weeks • acute abdominal pain or of unknown origin • nausea or vomiting • intestinal obstruction • esophageal or gastrointestinal stricture • rectal bleeding of unknown origin • failure to defecate following the use of laxatives • severe state of dehydration • dysphagia, hiatal hernia or conditions which pose a risk of regurgitation • atony of the colon • megacolon • faecal impaction • children under 12 years of age • pregnancy and breast-feeding (see section 4.6) • Crohn's disease, ulcerative colitis and appendicitis\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage The correct dose is the minimum sufficient to produce an easy evacuation of soft stools. It is recommended to initially use the minimum doses envisaged. When necessary, the dose can be increased. Do not exceed the maximum recommended daily dose. \u003cstrong\u003eAdults and adolescents over 12 years:\u003c\/strong\u003e The recommended dose is 5 g or 10 g of granules (corresponding to 1 - 2 measuring spoons) once a day. 1-2 sachets of 5 g once a day. Do not exceed the maximum recommended daily dose. \u003cb\u003eChildren \u003c\/b\u003e Agiolax is contraindicated in children under 12 years of age (see section 4.3). A unit dose of 5 g of granules contains: 2.6 g of Ispagula seed 0.11 g of Ispagula cuticle 0.34 - 0.66 g of Senna fruit \u003cu\u003eMethod of administration\u003c\/u\u003e For oral use. The granules should not be chewed or dissolved, but must be placed on the tongue and swallowed, standing upright, drinking a large glass of water. Agiolax should always be taken with liquids. Without sufficient fluids, the product may swell and obstruct the pharynx or esophagus, creating a risk of suffocation (see section 4.4). It can be taken regardless of meals. Take preferably in the evening, one hour before bedtime. Use the graduated measuring spoon supplied with the package. \u003cu\u003eDuration of treatment\u003c\/u\u003e Laxatives should be used as infrequently as possible and should not be used for more than 7 days. If after 3 days no improvements are observed or abdominal pain or bowel irregularities arise, re-evaluate the clinical picture. Prolonged use should be established after adequate clinical evaluation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g, 250 g, 400 g container: Store below 25°C Sachets: Store below 30°C. Keep in the original packaging in order to protect the medicine from moisture.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eWarnings\u003c\/b\u003e Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible, which can cause cardiac or neuromuscular dysfunction especially in case of simultaneous treatment with some medicinal products (see section 4.5). The abuse of laxatives, especially contact laxatives (stimulant laxatives), can cause addiction (possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). During treatment with Agiolax it is necessary to ingest a large quantity of water (6-8 glasses per day) to prevent the onset of intestinal obstruction. Agiolax should be used only if a therapeutic effect cannot be achieved by changing the diet or administering bulking laxatives. The use of laxatives concomitantly with thyroid hormones may make it necessary to adjust the dose of thyroid hormones. Given the risk of gastrointestinal obstruction, Agiolax should not be used together with medicinal products known to inhibit peristaltic movement (see section 4.5). After oral intake or skin contact Agiolax may cause hypersensitivity reactions (see section 4.8). Abdominal pain, spasms and diarrhea may occur, especially in the case of pre-existing irritable bowel syndrome (see section 4.8). These symptoms can also arise following overdose; in this circumstance it is necessary to reduce the dose (see section 4.9). Important information about some excipients Agiolax contains sucrose: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypokalaemia (resulting from long-term abuse of laxatives) potentiates the effects of cardiac glycosides and interacts with antiarrhythmic medicinal products, medicinal products that induce sinus rhythm reversal (e.g. quinidine) and medicinal products that induce QT prolongation. Concomitant use of diuretics, corticosteroids and licorice root may increase electrolyte imbalance. Laxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally (e.g. vitamin B12, coumarin derivatives, lithium and carbamazepine). Concomitant administration of antidiabetics may increase the risk of hypoglycemia. Avoid ingesting laxatives and other medicines at the same time: leave an interval of at least 2 hours before or after taking the laxative and another medicine. Agiolax may potentiate the risk of occlusion from opioid-induced reduced peristalsis (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSide effects are reported according to system organ class according to MedDRA. Undesirable effects are listed using the MedDRA frequency convention: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥ 1\/1000, \u003c 1\/100); rare ≥ 1\/10,000, \u003c 1\/1000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). Undesirable effects are presented in order of decreasing severity.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Rare (≥ 1\/10,000, ≤ 1\/1,000): Abdominal colic*, Flatulence, Abdominal distension, Gastrointestinal obstruction, Faecal impaction. Very rare (≤1\/10,000): Obstruction of the esophagus. Not known: Nausea, Vomiting, Diarrhoea.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders - Rare (≥ 1\/10,000, ≤ 1\/1,000): Chromaturia***. Not known: Albuminuria**, Haematuria**.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Not known: Hypersensitivity reactions, Anaphylactic reactions, Rash, Pruritus.\u003c\/p\u003e\n\u003cp\u003e*more frequently in case of severe constipation or irritable bowel syndrome; ** from prolonged use; *** this coloring is due to the presence of senna components in the urine and is not clinically significant. Furthermore, melanosis of the colon which recedes after discontinuation of the medicinal product has been reported. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal spasms, abdominal pain, flatulence, intestinal obstruction and severe diarrhoea, in which case treatment should be suspended and the resulting losses of fluids and electrolytes must be replenished. Prolonged use of high doses of medicines containing anthraquinones may cause toxic hepatitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e Use during pregnancy is contraindicated due to the known genotoxicity of anthraquinones contained in senna (see section 4.3). \u003cu\u003eBreastfeeding\u003c\/u\u003e Small quantities of active anthraquinone metabolites, such as rhein, are excreted in breast milk, therefore the use of Agiolax during breast-feeding is contraindicated (see section 4.3). \u003cu\u003eFertility\u003c\/u\u003e No fertility studies have been conducted.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAgiolax does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Viatris Healthcare","offers":[{"title":"Default Title","offer_id":51730208358727,"sku":"023714037","price":15.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/viatris-healthcare-limited-agiolax-granulato-400-g-confezione-con-cucchiaio-dosatore-farmacia-dottor-tili-1213791076.jpg?v=1767154367"},{"product_id":"clisma-lax-133-ml-4-flaconi-soluzione-rettale","title":"Lax enema 133 ml 4 bottles rectal solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml contain 13.91 g of anhydrous monobasic sodium phosphate (NaH\u003csub\u003e2\u003c\/sub\u003ePO\u003csub\u003e4\u003c\/sub\u003e); 3.18 g of dibasic sodium phosphate (Na\u003csub\u003e2\u003c\/sub\u003eHPO\u003csub\u003e4\u003c\/sub\u003e). Excipients with known effects: sodium benzoate (100mg per 100ml) and methylparahydroxybenzoate (50mg per 100ml). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium hydroxide, sodium benzoate, methyl parahydroxybenzoate, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e-Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - acute abdominal pain or of unknown origin - nausea or vomiting - intestinal obstruction or stenosis or anorectal stenosis - intestinal sub-occlusion - mechanical ileus - paralytic ileus - inflammatory intestinal disorders and other conditions that can increase the absorption of the medicine - anal perforation - congenital or acquired megacolon - Hirschsprung's disease - rectal bleeding of unknown origin - acute haemorrhoidal crisis with pain and bleeding - severe state of dehydration - children under the age of twelve. Phosphates are contraindicated in patients with cardiac disorders, severe renal insufficiency or in the presence of hyperphosphatemia. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and adolescents (12-18 years): the entire dose of the bottle. \u003cu\u003eMethod of administration\u003c\/u\u003e Do not exceed the recommended doses. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Take preferably in the evening.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePediatric population\u003c\/u\u003e: The 133 ml bottle should not be used in children under 12 years of age. Abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Patients should be encouraged to drink fluids to help prevent dehydration, particularly patients with conditions that may predispose to dehydration, or those taking medications that may decrease the glomerular filtration rate, such as diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (sartans), or nonsteroidal anti-inflammatory drugs (NSAIDs). Since Clisma lax contains sodium phosphates, there is a risk of elevated serum sodium and phosphate levels and decreased calcium and potassium levels, and consequently hypernatraemia, hyperphosphataemia, hypocalcaemia and hypokalaemia, which may occur with clinical signs such as tetany and renal failure. Abuse of laxatives can cause dependence (and, therefore, possible need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). Repeated use of laxatives can give rise to addiction or various types of damage. Prolonged use of a laxative to treat constipation is not recommended. The pharmacological treatment of constipation must be considered an adjuvant to the hygienic-dietary treatment (e.g. increase in vegetable fibers and liquids in the diet, physical activity and re-education of intestinal motility). The treatment of chronic or recurrent constipation always requires the intervention of a doctor for diagnosis, prescription of drugs and monitoring during the course of therapy. A careful evaluation by the doctor is essential when the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects. Elderly people or those in poor health and patients with uncontrolled arterial hypertension, ascites, heart disease, changes in the rectal mucosa (ulcers, fissures) should consult their doctor before using the medicine. Patients should be advised to discontinue administration if resistance is encountered, as forcible administration of the enema may cause injury. In episodes of constipation, it is recommended first of all to correct eating habits by integrating the daily diet with an adequate intake of fiber and water. When using laxatives it is advisable to drink at least 6-8 glasses of water or other liquids a day to help soften the stool.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe systemic absorption of sodium phosphate rectal solution is limited, however in some conditions it may be increased and predispose to possible interactions with other drugs. The simultaneous intake of drugs that can have effects on electrolyte balance (such as diuretics, cortisone, calcium channel blockers, lithium) can facilitate the onset of hyperphosphatemia, hypercalcemia and hypernatremia. Patients taking drugs that can prolong the QT interval may be at greater risk of developing this adverse reaction if treated concomitantly with sodium phosphate. Since hypernatremia is associated with low lithium levels, the concomitant use of Enema lax and lithium may cause a reduction in serum lithium levels, with a decrease in efficacy. Concomitant use of calcium supplements or calcium-containing antacids may increase the risk of ectopic calcification. Other preparations with sodium phosphates, including oral solutions or sodium phosphate tablets, should not be administered simultaneously (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of sodium phosphate organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eImmune system disorders\u003c\/i\u003e Hypersensitivity reactions (e.g. urticaria) \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e Blisters, itching, burning \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e Isolated crampy pain or abdominal colic and diarrhea, with loss of fluids and electrolytes, more frequent in cases of severe constipation, as well as rectal irritation. Nausea, vomiting. \u003ci\u003eMetabolism and nutrition disorders\u003c\/i\u003e Hyperphosphatemia, hypokalemia, hypernatremia, hypocalcemia, and tissue calcification may rarely occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe effect most frequently observed following ingestion or rectal administration is gastrointestinal irritation (abdominal pain, nausea, vomiting, diarrhoea). Persistent diarrhea results in loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced. Electrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in the case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. Fluid and electrolyte losses must be replaced. Generally, conservative measures are sufficient; plenty of liquids must be given, especially fruit juices. See also what is reported in paragraph 4.4 regarding the abuse of laxatives. If a significant amount of phosphate is absorbed, hyperphosphatemia, hypocalcemia, and hypomagnesemia may occur. Alterations in fluid and electrolyte balance have been observed following oral, rectal and intravenous exposure. Severe hyperphosphatemia and hypocalcemia may cause tetany, convulsions, bradycardia, QT interval prolongation, arrhythmia, coma and cardiac arrest. Severe dehydration, hypernatremia, hypotension, metabolic acidosis, and tachycardia may also occur. The elderly, children and patients with renal insufficiency are at increased risk of toxic effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no adequate and well-controlled studies on the use of the medicine during pregnancy or breastfeeding. Therefore the medicine must be used only if necessary, under the direct supervision of the doctor, after having evaluated the expected benefit for the mother in relation to the possible risk for the fetus or infant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine does not alter the ability to drive or use machines. However, it is possible that side effects may occur during treatment, therefore it is good to know the reaction to the drug before driving vehicles or using machinery.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51730212061511,"sku":"024995045","price":17.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-clisma-lax-133-ml-4-flaconi-soluzione-rettale-farmacia-dottor-tili-1213791008.jpg?v=1767155829"},{"product_id":"verolax-3-g-6-monodose-soluzione-rettale","title":"Verolax 3 g 6 single-dose rectal solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConstipation.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eVerolax “6.75 g Adults Rectal Solution” 6 Single-dose Containers 9 G\u003c\/i\u003e: Each 9G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 6.75 g \u003ci\u003eVerolax “2.25 g Children Rectal Solution” 6 Single-dose Containers 3 G\u003c\/i\u003e: Each 3G single-dose container contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “2.25 g Adult Suppositories” 18 Suppositories\u003c\/i\u003e:Each adult suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 2.25 g \u003ci\u003eVerolax “1,375 g Children Suppositories” 18 Suppositories\u003c\/i\u003e: Each children's suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 1.375 g \u003ci\u003eVerolax “0.675 g Infant Suppositories” 12 Suppositories\u003c\/i\u003e: Each infant suppository contains: \u003ci\u003eActive ingredient\u003c\/i\u003e: glycerin 0.675 g\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution for adults and children:\u003c\/i\u003e Mallow fluid extract; Chamomile fluid extract; Wheat starch; Purified water. \u003ci\u003eSuppositories Adults, Children, Infants:\u003c\/i\u003e Sodium stearate, Sodium carbonate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIndividual hypersensitivity confirmed towards the product. Anorectal diseases, hemorrhagic rectocolitis and inflammation of hemorrhoids. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRectal solution:\u003c\/i\u003e 1 or 2 single-dose containers in 24 hours. In case of stubborn constipation, no more than 2 doses can be introduced into the rectum at the same time. \u003ci\u003eSuppositories:\u003c\/i\u003e 1 suppository as needed. Do not exceed the recommended doses.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo special precautions for storage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe continuous use of laxatives can cause addiction or damage of various types. Do not use laxatives if abdominal pain, nausea and vomiting are present. If constipation is stubborn, consult your doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interactions with other drugs have been found. \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe only effects that may be encountered are irritative, at the level of the rectal area. These are usually mild forms, which do not require medical intervention.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known symptoms of overdose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBased on its chemical-physical properties, rectal glycerin can be usefully used during pregnancy or the puerperium.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTaking the drug does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Angelini Acraf","offers":[{"title":"Default Title","offer_id":51730213273927,"sku":"026525042","price":5.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-a-c-r-a-f-spa-verolax-3-g-6-monodose-soluzione-rettale-farmacia-dottor-tili-1213791002.jpg?v=1767155951"},{"product_id":"eva-qu-suppositori-effervescenti-12-pezzi-evacuante","title":"Eva Qu effervescent suppositories 12 pieces evacuating","description":"\u003cp\u003e\u003cstrong\u003eEva Qu effervescent suppositories 12 pieces evacuating\u003c\/strong\u003e it's a \u003cstrong\u003eCE medical device\u003c\/strong\u003e of class I, designed to offer a \u003cstrong\u003eprompt relief from constipation\u003c\/strong\u003e and constipation, both in the case of occasional and recurrent episodes. Thanks to his \u003cstrong\u003eeffervescent action\u003c\/strong\u003e unique, Eva Qu stimulates the body in a natural and delicate way \u003cstrong\u003estimulus to evacuation\u003c\/strong\u003e, favoring one \u003cstrong\u003erapid evacuation\u003c\/strong\u003e and satisfactory without the use of pharmacologically active substances. This makes it particularly suitable for those looking for a \u003cstrong\u003enatural laxative\u003c\/strong\u003e and safe, also suitable during delicate periods such as pregnancy, breastfeeding, convalescence or at an advanced age.\u003c\/p\u003e\n\n\u003cp\u003eLe \u003cstrong\u003eeffervescent suppositories Eva Qu\u003c\/strong\u003e act locally thanks to the production of \u003cstrong\u003ecarbon dioxide\u003c\/strong\u003e (CO2) in contact with body temperature, generating numerous micro-bubbles that \"massage\" the walls of the rectum and soften stagnant stools. This mechanism promotes the separation of feces and a \u003cstrong\u003ephysiological defecation\u003c\/strong\u003e and natural, without systemic effects. The formulation contains \u003cstrong\u003esodium bicarbonate\u003c\/strong\u003e e \u003cstrong\u003epotassium bitartrate\u003c\/strong\u003e, safe and non-toxic ingredients, also used in the food sector.\u003c\/p\u003e\n\n\u003cp\u003eEva Qu is also ideal as \u003cstrong\u003epreparation for medical exams\u003c\/strong\u003e (rectoscopy, surgical, gastroenterological, urological visits) and represents a valid help during travel, when constipation can become a stubborn problem. His \u003cstrong\u003erectal use\u003c\/strong\u003e it is simple and quick, and the 12-piece pack guarantees prolonged coverage for every need. Choose Eva Qu for a \u003cstrong\u003enatural, effective and delicate remedy against constipation\u003c\/strong\u003e, suitable for the entire adult family and also for those with motor disabilities.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Eva Qu effervescent suppositories 12 pieces evacuant? What is it for?\u003c\/h3\u003e\u003cp\u003eEva Qu effervescent suppositories 12 pieces evacuant is a CE medical device, class I, indicated for the treatment of occasional or recurrent constipation. Its local action, without systemic effects, also makes it suitable during pregnancy, breastfeeding, convalescence, advanced age and for those with motor disabilities. It is also indicated before medical procedures such as rectal examination, surgical, gastroenterological, urological and procto-rectoscopy visits.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Eva Qu effervescent suppositories 12 pieces evacuant?\u003c\/h3\u003e\u003cp\u003eUse one or more suppositories for each treatment. Once introduced into the anal cavity, the eva\/qu suppository is in close contact with the body temperature. After about 3-4 minutes the suppository dissolves and releases the CO2 responsible for the effervescent effect characterized by the production of many micro-bubbles. The \"bubbles\" formed exert a local effect by \"massaging\" the walls of the rectum. Furthermore, the dissolved suppository softens the stagnant stools located at the level of the rectal ampulla, promoting detachment and a quick and satisfactory evacuation. The repeated use of the evaqu suppository also favors the rehabilitation of the \"sluggish\" physiological defecation mechanism.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Eva Qu effervescent suppositories 12 pieces evacuant?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eContraindications\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThere are no contraindications to the use of eva\/qu evacuating suppositories. The suppository can also be used in the presence of hemorrhoids or local lesions - even if used frequently and for a long time. The suppository is made of natural and completely non-toxic substances (sodium bicarbonate, potassium bitartrate) also used in many food preparations.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eEva\/qu suppositories for adults are not indicated in children and adolescents under 12 years of age. Use one or more suppositories for each treatment. A sensation of incomplete emptying or a modest temporary burning sensation should not cause concern. They resolve quickly. The suppository contains polyethylene glycol which may cause irritation.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Eva Qu effervescent suppositories 12 pieces evacuant?\u003c\/h3\u003e\u003cp\u003ePack of 6 or 12 pieces.\u003c\/p\u003e","brand":"Sose Pharm","offers":[{"title":"Default Title","offer_id":51821897580871,"sku":"933753170","price":12.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/so-se-pharm-srl-eva-qu-suppositori-effervescenti-12-pezzi-evacuante-farmacia-dottor-tili-1213790787.jpg?v=1767165749"},{"product_id":"miscela-3-oli-lassativi-250-ml-dispositivo-medico","title":"Laxative oil blend 250 ml","description":"\u003cp\u003e\n\u003cstrong\u003eMixture of 3 laxative oils 250 ml medical device\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e specifically formulated to promote intestinal regularity and facilitate evacuation in case of \u003cstrong\u003eoccasional constipation\u003c\/strong\u003e. Thanks to its composition based on \u003cstrong\u003eVaseline oil, olive oil and almond oil\u003c\/strong\u003e in equal parts, this mixture acts as \u003cstrong\u003elubricating oily laxative\u003c\/strong\u003e, ideal for those who need one \u003cstrong\u003esofter fecal mass\u003c\/strong\u003e and of a \u003cstrong\u003efaster intestinal flow\u003c\/strong\u003e, especially in the presence of \u003cstrong\u003ediverticula\u003c\/strong\u003e or after abdominal surgery.\n\u003c\/p\u003e\n\u003cp\u003e\nThe \u003cstrong\u003eBlend 3 laxative oils\u003c\/strong\u003e coats the fecal material and creates a \u003cstrong\u003elipid film\u003c\/strong\u003e along the intestinal walls, slowing down the physiological absorption of water. This mechanism allows water to remain in the intestine, contributing to \u003cstrong\u003esoften the stool\u003c\/strong\u003e and to facilitate its passage without irritating the intestinal mucosa. The product is particularly suitable for those who cannot make efforts during the evacuation, guaranteeing a \u003cstrong\u003efacilitated evacuation\u003c\/strong\u003e and safe.\n\u003c\/p\u003e\n\u003cp\u003e\nThe \u003cstrong\u003eMixture of 3 laxative oils 250 ml\u003c\/strong\u003e it is recommended as \u003cstrong\u003enatural remedy for constipation\u003c\/strong\u003e and for the \u003cstrong\u003etreatment of constipation\u003c\/strong\u003e, offering a delicate but effective action. The 250 ml format is practical and suitable for oral use, ensuring a \u003cstrong\u003eregulation of intestinal transit\u003c\/strong\u003e and daily support for the well-being of\u003cstrong\u003egastrointestinal system\u003c\/strong\u003e. Choose this solution for one \u003cstrong\u003eregular evacuation\u003c\/strong\u003e and a \u003cstrong\u003eintestinal lubricant\u003c\/strong\u003e of proven effectiveness.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should you use Blend 3 laxative oils 250 ml? What is it for?\u003c\/h3\u003e\u003cp\u003eBlend of 3 laxative oils 250 ml medical device is a medical device specifically formulated to promote intestinal regularity and facilitate evacuation in case of occasional constipation.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Blend 3 laxative oils 250 ml contain?\u003c\/h3\u003e\u003cp\u003eVaseline oil, olive oil, \u003cstrong\u003ealmond oil\u003c\/strong\u003e in equal parts.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Blend 3 laxative oils 250 ml?\u003c\/h3\u003e\u003cp\u003e- From 6 to 11 years: 2-3 teaspoons per day, in a single administration.\u003cbr\u003e- From 12 years: 2-3 tablespoons per day, in a single administration.\u003c\/p\u003e\u003cp\u003eShake the bottle before use. Take the product during or after meals, preferably in the evening at least one hour before bedtime.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Miscela 3 laxative oils 250 ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eProducts with a laxative effect should be used as infrequently as possible and for no longer than seven days.\u003cbr\u003eIt is not recommended in children under 6 years.\u003cbr\u003eA diet rich in liquids favors the effect of the product.\u003cbr\u003eKeep out of the reach and sight of children.\u003cbr\u003eIf undesirable effects occur, treatment must be suspended and the doctor must be informed.\u003cbr\u003eDo not use the medical device if, when first opened, the packaging is damaged or not perfectly intact.\u003cbr\u003eDo not use in case of:\u003cbr\u003e- hypersensitivity (allergy) towards one of the two components;\u003cbr\u003e- nausea, vomiting, acute abdominal pain or pain of unknown origin;\u003cbr\u003e- intestinal obstruction or stenosis;\u003cbr\u003e- disorders affecting the gastrointestinal system such as appendicitis, ulcerative colitis, rectal bleeding of unknown origin;\u003cbr\u003e- pregnancy or during breastfeeding;\u003cbr\u003e- acute hemorrhoidal crisis with pain and bleeding;\u003cbr\u003e- severe state of dehydration;\u003cbr\u003e- subjects with difficulty in ingesting or who have pathologies (for example hiatal hernia) or conditions (for example debilitated subjects confined to bed) which involve the risk of regurgitation;\u003cbr\u003e- colostomy\/ileostomy;\u003cbr\u003e- concomitant intake of other laxatives or stool softeners.\u003c\/p\u003e\u003cp\u003ePossible side effects:\u003cbr\u003eMetabolism and nutrition disorders.\u003cbr\u003eLiquid paraffin can interfere with the absorption of fat-soluble substances, such as vitamins A, D, E, K, especially following prolonged use of the product.\u003cbr\u003eIsolated crampy pain or abdominal colic, more frequent in cases of severe constipation.\u003cbr\u003eRectal dripping (leakage) of paraffin resulting in anal irritation and itching, rectal bleeding, especially following prolonged use of the product.\u003cbr\u003eLipoid pneumonia and oil embolism, due to accidental inhalation of the product.\u003c\/p\u003e\u003cp\u003eOverdose and abuse:\u003cbr\u003eThe abuse of preparations with a laxative effect (frequent or prolonged use or with excessive doses) can cause abdominal pain, persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. Fluid and electrolyte losses must be replaced.\u003cbr\u003eElectrolyte imbalances are characterized by the following symptoms: thirst, vomiting, weakness, edema, bone pain (osteomalacia) and hypoalbuminemia. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids.\u003cbr\u003eIf episodes of constipation occur repeatedly, a doctor should be consulted.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should it not be used Mixture of 3 laxative oils 250 ml and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not use in case of:\u003cbr\u003e- hypersensitivity (allergy) towards one of the two components;\u003cbr\u003e- nausea, vomiting, acute abdominal pain or pain of unknown origin;\u003cbr\u003e- intestinal obstruction or stenosis;\u003cbr\u003e- disorders affecting the gastrointestinal system such as appendicitis, ulcerative colitis, rectal bleeding of unknown origin;\u003cbr\u003e- pregnancy or during breastfeeding;\u003cbr\u003e- acute hemorrhoidal crisis with pain and bleeding;\u003cbr\u003e- severe state of dehydration;\u003cbr\u003e- subjects with difficulty in ingesting or who have pathologies (for example hiatal hernia) or conditions (for example debilitated subjects confined to bed) which involve the risk of regurgitation;\u003cbr\u003e- colostomy\/ileostomy;\u003cbr\u003e- concomitant intake of other laxatives or stool softeners.\u003cbr\u003e\u003cbr\u003ePossible side effects:\u003cbr\u003eMetabolism and nutrition disorders.\u003cbr\u003eLiquid paraffin can interfere with the absorption of fat-soluble substances, such as vitamins A, D, E, K, especially following prolonged use of the product.\u003cbr\u003eIsolated crampy pain or abdominal colic, more frequent in cases of severe constipation.\u003cbr\u003eRectal dripping (leakage) of paraffin resulting in anal irritation and itching, rectal bleeding, especially following prolonged use of the product.\u003cbr\u003eLipoid pneumonia and oil embolism, due to accidental inhalation of the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow to store Mixture of 3 laxative oils 250 ml?\u003c\/h3\u003e\u003cp\u003eStore, tightly closed, in a cool place, away from heat sources and protected from light.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Blend 3 laxative oils 250 ml?\u003c\/h3\u003e\u003cp\u003e250 ml bottle\u003c\/p\u003e","brand":"Sella","offers":[{"title":"Default Title","offer_id":51821906166087,"sku":"973145865","price":6.98,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sella-srl-miscela-3-oli-lassativi-250-ml-dispositivo-medico-farmacia-dottor-tili-1213790917.jpg?v=1767167908"},{"product_id":"redipeg-20-stick-pack-30-ml-evacuante-pediatrico","title":"Redipeg 20 sticks 30 ml pediatric evacuant","description":"\u003cp\u003e\n\u003cstrong\u003eRedipeg 20 stick packs 30 ml pediatric evacuant\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e specifically formulated for \u003cstrong\u003etreatment of chronic constipation\u003c\/strong\u003e both in \u003cstrong\u003echildren\u003c\/strong\u003e that in \u003cstrong\u003eadults\u003c\/strong\u003e. Thanks to the presence of \u003cstrong\u003eMacrogol 4000\u003c\/strong\u003e, Redipeg acts as \u003cstrong\u003eosmotic solution\u003c\/strong\u003e that \u003cstrong\u003esoftens stool\u003c\/strong\u003e facilitating evacuation, without causing \u003cstrong\u003ecramps\u003c\/strong\u003e or \u003cstrong\u003eabdominal pain\u003c\/strong\u003e and without irritating the intestinal mucosa. Macrogol is not absorbed or fermented in the intestine, ensuring a delicate and safe action even for a \u003cstrong\u003epediatric use\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nThe formulation is enriched with \u003cstrong\u003eSimethicone\u003c\/strong\u003e, an active ingredient that has an effective anti-foam action, helping to reduce the \u003cstrong\u003eabdominal swelling\u003c\/strong\u003e and the \u003cstrong\u003eproduction of intestinal gas\u003c\/strong\u003e often associated with \u003cstrong\u003echronic constipation\u003c\/strong\u003e. Redipeg is indicated to promote \u003cstrong\u003eintestinal regularity\u003c\/strong\u003e and the \u003cstrong\u003eintestinal well-being\u003c\/strong\u003e in a practical and quick way, thanks to the 30 ml single-dose stick pack format, which can be easily used even outside the home.\n\u003c\/p\u003e\n\u003cp\u003e\nRedipeg 20 stick pack 30 ml pediatric evacuant is ideal for those looking for an effective and well-tolerated solution for \u003cstrong\u003eintestinal regularity\u003c\/strong\u003e in children and adults, without annoying side effects. Its effectiveness remains constant over time, making it also suitable for prolonged treatments in case of \u003cstrong\u003erefractory constipation\u003c\/strong\u003e or linked to particular clinical conditions. The pleasant orange flavor and the practicality of the disposable sachets make Redipeg a reliable choice for the whole family.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Redipeg 20 stick 30 ml pediatric evacuant used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on macrogol 4000 and simethicone, indicated for the treatment of chronic constipation in children and adults; promotes the softening of stools and helps reduce abdominal swelling linked to constipation.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Redipeg 20 sticks 30 ml pediatric evacuant contain?\u003c\/h3\u003e\u003cp\u003eMacrogol 4,000, simethicone; excipients: water, sucralose, orange flavouring, vegetable glycerin, polysorbate 80, sucrose esters, potassium sorbate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Redipeg 20 sticks 30 ml pediatric evacuant?\u003c\/h3\u003e\u003cp\u003eChildren from 1 to 6 years: 1 sachet per day.\u003cbr\u003eAdults and children from 6 years: 2 sachets per day.\u003cbr\u003eIt is recommended to take the product between meals. If the conditions still persist after taking the product, it is advisable to consult your doctor. Take the product directly from the sachet or first dilute the product in a little water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Redipeg 20 stick 30 ml pediatric evacuant?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not take Redipeg if you:\u003cbr\u003e- intestinal stenosis;\u003cbr\u003e- intestinal perforation;\u003cbr\u003e- irritable bowel syndrome (e.g. Chron's disease, ulcerative colitis).\u003cbr\u003eDo not take in case of intestinal obstruction.\u003cbr\u003eThere is no experience on taking it during pregnancy and breastfeeding, so it is recommended to take Redipeg only when necessary on medical advice. in patients with real impairment, it is not necessary to adjust the dosage. The duration of treatment with Redipeg should not exceed 2 weeks. If necessary, the treatment can be repeated. Prolonged use may be necessary in cases of refractory and\/or chronic constipation. This type of refractory constipation can be caused by drugs, painkillers (opioids) and drugs to treat Parkinson's (anticholinergics), or appear in the case of diseases such as multiple sclerosis or Parkinson's disease.\u003cbr\u003eSometimes gastrointestinal disorders, borborygmi, abdominal pain, nausea and mild diarrhea may appear (especially at the beginning). Rarely, hypersensitivity reactions (rush and urticaria) may occur. However, if intolerance or other side effects occur, stop treatment immediately and consult your doctor. If symptoms persist, consult your doctor.\u003cbr\u003eWhen ingested concomitantly with other drugs, Redipeg could change their bioavailability. In particular, the osmotic power of macrogol and the greater speed of induced gastrointestinal transit can negatively influence their effectiveness. Therefore, it is advisable that the intake of the product is postponed for at least 2 hours after the administration of drugs taken orally or food supplements. In any case, consult your doctor before taking Redipeg in the case of other ongoing therapies.\u003cbr\u003eDo not use if the bag is damaged.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eDo not use the product under 1 year of age.\u003cbr\u003eBefore using the product in children, it is advisable to consult your doctor.\u003cbr\u003eDo not take the product after the expiry date.\u003cbr\u003eIf you are pregnant or breastfeeding, take the product only if necessary and after consulting a doctor. During treatment with Redipeg it is advisable to follow an adequate diet and take oral rehydration solutions (ORS) in order to prevent dehydration.\u003cbr\u003eIt is also advisable to consult your doctor. Do not use Redipeg for more than 30 consecutive days. If symptoms persist, consult your doctor. Do not take in case of intolerance to the product. Do not take in case of known hypersensitivity to the components and polyethylene glycol. Each bag is disposable and should only be opened when used. Simethicone may interfere with the effect of some reagents used in diagnostics, such as guaiac gum.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Redipeg 20 stick 30 ml pediatric evacuant not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not take Redipeg if you:\u003cbr\u003e- intestinal stenosis;\u003cbr\u003e- intestinal perforation;\u003cbr\u003e- irritable bowel syndrome (e.g. Chron's disease, ulcerative colitis).\u003cbr\u003eDo not take in case of intestinal obstruction.\u003cbr\u003e\u003cbr\u003eSometimes gastrointestinal disorders, borborygmi, abdominal pain, nausea and mild diarrhea may appear (especially at the beginning). Rarely, hypersensitivity reactions (rush and urticaria) may occur. However, if intolerance or other side effects occur, stop treatment immediately and consult your doctor. If symptoms persist, consult your doctor.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINTERACTIONS\u003c\/h2\u003e\n\u003ch3\u003eWhich medicines or foods can modify the effect of Redipeg 20 stick 30 ml pediatric evacuant?\u003c\/h3\u003e\u003cp\u003eWhen ingested concomitantly with other drugs, Redipeg could change their bioavailability. In particular, the osmotic power of macrogol and the greater speed of induced gastrointestinal transit can negatively influence their effectiveness. Therefore, it is advisable that the intake of the product is postponed for at least 2 hours after the administration of drugs taken orally or food supplements. In any case, consult your doctor before taking Redipeg in the case of other ongoing therapies.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Redipeg 20 sticks 30 ml pediatric evacuant stored?\u003c\/h3\u003e\u003cp\u003eStore Redipeg in a dry place and away from direct heat or light sources.\u003cbr\u003eOpen the sachet only when in use.\u003cbr\u003eKeep the device at a temperature between 15°C and 25°C.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Redipeg 20 stick 30 ml pediatric evacuant?\u003c\/h3\u003e\u003cp\u003e20 sachets of 30 ml.\u003c\/p\u003e","brand":"Aurora Biofarma","offers":[{"title":"Default Title","offer_id":51821910065479,"sku":"981441987","price":22.33,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aurora-biofarma-redipeg-20-stick-30-ml-evacuante-pediatrico-farmacia-dottor-tili-1254211065.jpg?v=1786729032"},{"product_id":"klister-enteroclisma-da-viaggio-2-litri-ripiegabile","title":"2 Liter Foldable Travel Enema Klister","description":"\u003cp\u003e\u003cstrong\u003eTravel Enema Klister\u003c\/strong\u003e is an enema with a capacity of \u003cstrong\u003e2 litres\u003c\/strong\u003e, and what distinguishes it from others is in the name: yes \u003cstrong\u003efold back\u003c\/strong\u003e inside its own packaging, which is made to fit in a suitcase.\u003c\/p\u003e\u003cp\u003eThe enema is the simplest of the devices for\u003cstrong\u003erectal irrigation\u003c\/strong\u003e, and it is simple because it has no moving parts: there is a flexible container, a tube and a cannula, and the liquid flows down \u003cstrong\u003egravity\u003c\/strong\u003e. You hang the container higher than your body and the height difference does all the work; the higher the container, the faster the flow. It's the reason why such an appliance doesn't break down and doesn't need maintenance. The \u003cstrong\u003eflow by gravity\u003c\/strong\u003e and the \u003cstrong\u003enon-toxic material\u003c\/strong\u003e I am \u003cstrong\u003euseful\u003c\/strong\u003e in case of \u003cstrong\u003erectal irrigation at home\u003c\/strong\u003e and of \u003cstrong\u003erepeated use over time\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eThe \u003cstrong\u003enon-toxic material\u003c\/strong\u003e it is the characteristic that the manufacturer declares, and it is the one that counts on a device that comes into contact with a mucosa. The rectal mucosa absorbs, and absorbs quickly: what touches the wall is not indifferent as it would be on intact skin.\u003c\/p\u003e\u003cp\u003eThe packaging brings the \u003cstrong\u003eanal cannula\u003c\/strong\u003e e \u003cstrong\u003evaginal\u003c\/strong\u003e. They are two different uses, and the second is the reason why this appliance also appears among the products for\u003cstrong\u003eintimate hygiene\u003c\/strong\u003e and not only among those for the intestine.\u003c\/p\u003e\u003cp\u003eI \u003cstrong\u003e2 litres\u003c\/strong\u003e they are the capacity that the manufacturer declares, and it is the full size of the device, not the dose: how much is used depends on who prescribed it. The format \u003cstrong\u003efoldable\u003c\/strong\u003e it solves the practical problem of those who use enemas regularly and don't want to give it up outside the home, which is the difference between a device that is used and one that remains in the closet.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should I use the 2 Liter Foldable Travel Enema Klister? What is it for?\u003c\/h3\u003e\u003cp\u003eEnteroclysm \u003cstrong\u003efor travel\u003c\/strong\u003e made in \u003cstrong\u003enon-toxic material\u003c\/strong\u003e, foldable in travel packaging. With anal and vaginal cannula.\u003c\/p\u003e\u003cp\u003eCapacity: \u003cstrong\u003e2 litres\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of the 2 Liter Foldable Travel Enema Klister?\u003c\/h3\u003e\u003cp\u003ePack containing 1 piece, with cannula.\u003c\/p\u003e","brand":"Safety","offers":[{"title":"Default Title","offer_id":54137677578567,"sku":"908924626","price":10.4,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/safety-spa-klister-enteroclisma-viaggio-farmacia-dottor-tili-1244017738.jpg?v=1781245038"},{"product_id":"pediapax-20-bustine-polvere-stitichezza-bambini","title":"Pediapax 20 Sachets of Constipation Powder for Children","description":"\u003cp\u003e\u003cstrong\u003ePediapax\u003c\/strong\u003e it is a medical device \u003cstrong\u003e20 divisible sachets\u003c\/strong\u003e 13.125 g, in powder to be dissolved, for the \u003cstrong\u003echronic constipation\u003c\/strong\u003e of the children above i \u003cstrong\u003e2 years\u003c\/strong\u003e and for the \u003cstrong\u003efecal impaction\u003c\/strong\u003e come on \u003cstrong\u003e3 years\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eThe principle is the \u003cstrong\u003ePEG\u003c\/strong\u003e, polyethylene glycol, and is a different way of acting than laxatives that stimulate the intestine. PEG is a polymer \u003cstrong\u003einert\u003c\/strong\u003e, which is neither absorbed nor metabolised: it remains in the intestine and there \u003cstrong\u003eholds water\u003c\/strong\u003e for \u003cstrong\u003eosmotic effect\u003c\/strong\u003e. The retained water \u003cstrong\u003esoftens\u003c\/strong\u003e the fecal mass and increases its volume, and the volume is what recalls peristalsis. It is \u003cstrong\u003euseful\u003c\/strong\u003e in case of \u003cstrong\u003ehard stools\u003c\/strong\u003e and difficult evacuation, and the practical difference is that it does not irritate the wall: it acts on the water, not on the nerves.\u003c\/p\u003e\u003cp\u003eThe fact that the sachet is \u003cstrong\u003edivisible\u003c\/strong\u003e this is the reason why this product is pediatric: it allows you to adapt the quantity to the age of the child while remaining in the same package, something that a sealed single-dose sachet does not allow. Under 2 years the range includes the bottle with measuring spoon, where the dosage is finer than this.\u003c\/p\u003e\u003cp\u003eThe \u003cstrong\u003efecal impaction\u003c\/strong\u003e it is the other use, and it is something different from constipation: it is not a slower transit, it is a fecal load that \u003cstrong\u003eobstructs\u003c\/strong\u003e, and the manufacturer wants it confirmed by a \u003cstrong\u003ephysical or radiological examination\u003c\/strong\u003e. The \u003cstrong\u003ePEG\u003c\/strong\u003e it is \u003cstrong\u003euseful in case of chronic constipation\u003c\/strong\u003e, hard stools and difficult evacuation in the child.\u003c\/p\u003e\u003cp\u003eThe dust is \u003cstrong\u003esoluble\u003c\/strong\u003e not only in water but also in \u003cstrong\u003etea\u003c\/strong\u003e, \u003cstrong\u003emilk\u003c\/strong\u003e, \u003cstrong\u003ebroth\u003c\/strong\u003e or \u003cstrong\u003efruit juice\u003c\/strong\u003e, which with a child is often the difference between an accepted preparation and a rejected one.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePediapax 20 Sachets of Constipation Powder for Children\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e in case from \u003cstrong\u003e20 divisible sachets\u003c\/strong\u003e from 13.125 g of \u003cstrong\u003epowder to dissolve\u003c\/strong\u003e, for children come on \u003cstrong\u003e2 years\u003c\/strong\u003e.\u003c\/p\u003e\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should you use Pediapax 20 Sachets Powder for Constipation in Children? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device in powder form for extemporaneous oral suspension, useful in the treatment of \u003cstrong\u003echronic constipation\u003c\/strong\u003e in children older than \u003cstrong\u003e2 years\u003c\/strong\u003e and weighing equal to or greater than \u003cstrong\u003e10kg\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eAlso useful in the treatment of \u003cstrong\u003efecal impaction\u003c\/strong\u003e in children come on \u003cstrong\u003e3 years\u003c\/strong\u003e, defined as refractory constipation with fecal load in the rectum or colon.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Pediapax 20 Sachets Powder for Constipation in Children?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eChronic constipation.\u003c\/strong\u003e The usual starting dose is \u003cstrong\u003ehalf a sachet a day\u003c\/strong\u003e in children between 2 and 6 years of age \u003cstrong\u003eone sachet a day\u003c\/strong\u003e from 7 years of age, dissolved in 125 ml of non-carbonated water (about 1 glass) for the whole sachet and in 62.5 ml (about half a glass) for the half sachet. You can dissolve the product in a liquid other than water, such as tea, milk, broth or fruit juice.\u003c\/p\u003e\u003cp\u003eThe dose can be increased or decreased to allow regular evacuation of soft stools. If you need to increase it, it is best to do it every 2 days. The maximum dose needed does not normally exceed 2 sachets per day. In the case of prolonged treatment, proceed with gradual interruption and restart if constipation reappears. Do not use the product for more than 30 consecutive days; if symptoms persist, consult your doctor.\u003c\/p\u003e\u003cp\u003ePediapax can also be used under 2 years of age, starting from 6 months: for this age group, for a more precise definition of the dosage, the formulation in a bottle with measuring spoon is available.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eFecal impaction.\u003c\/strong\u003e The diagnosis of fecal impaction or fecal load in the rectum must be confirmed by a physical or radiological examination of the abdomen and rectum. A treatment cycle lasts from 3 to a maximum of 6 consecutive days, with this number of sachets per day:\u003cbr\u003efrom 3 to 6 years: 2 sachets\u003cbr\u003efrom 7 to 10 years: 3 sachets\u003cbr\u003eover 10 years: 4 sachets\u003c\/p\u003e\u003cp\u003eBy sachet we mean the whole 13.125 g sachet, i.e. 2 half sachets. The daily number should be taken divided into doses of 6.563 g (half a sachet) to be dissolved in 62.5 ml of water, all consumed within 12 hours. The interval between one intake and the next depends on how many sachets you take:\u003cbr\u003e2 sachets per day: 4 half sachets, one every 3 hours\u003cbr\u003e3 sachets a day: 6 half sachets, one every 2 hours\u003cbr\u003e4 sachets a day: 8 half sachets, one every hour and a half\u003c\/p\u003e\u003cp\u003eTo customize the dosage you can consider a dosage of 1-1.5 g per kg per day. The pattern should be stopped once the blockage has resolved, and one indicator of resolution is the passage of a large amount of stool. After resolution, it is recommended that the child follow an appropriate bowel treatment program to prevent a new fecal impaction.\u003c\/p\u003e\u003cp\u003eIt is possible to prepare a larger volume of ready solution, for example by dissolving 6 sachets in 750 ml of water: in this case the solution can be stored covered in the refrigerator for a maximum of 24 hours, and then discarded.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Pediapax 20 Sachets Powder Constipation for Children?\u003c\/h3\u003e\u003cp\u003eKeep the device and any solution obtained out of the reach of children. Do not use after the expiry date shown on the package and sachet, nor in case of damaged packaging. Each sachet is disposable and must only be opened immediately before consumption: do not reuse sachets that have been partially used or opened at unknown times, because this method of use could lead to risks of contamination of the product.\u003c\/p\u003e\u003cp\u003eDo not exceed the recommended doses: in case of overdose, intense pain and abdominal distension may occur. Furthermore, induced diarrhea may occur, with electrolyte disturbances caused by possible excessive evacuation. In case of suspected overdose, contact your pediatrician immediately. When Pediapax is used in high doses to treat faecal impaction, it should be administered with caution to patients with impaired swallowing reflex, reflux esophagitis, or reduced levels of consciousness. If you miss a dose, do not take a double one to make up. During treatment it is advisable to follow an adequate diet, accompanied by the administration of an oral rehydration solution to avoid dehydration. However, it is advisable to consult your doctor.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eKnown side effects.\u003c\/strong\u003e Gastrointestinal disorders such as abdominal pain, borborygmi, diarrhea or loose stools may appear, especially in the initial phase of use, as well as nausea, mild vomiting, abdominal distension, flatulence, inflammation and perianal irritation: effects which normally improve by reducing the dose. Very rarely, allergic reactions, including anaphylaxis, and other symptoms such as itching, urticaria and dyspnoea have been observed. In case of persistence, suspend treatment and contact your pediatrician.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eContraindications and limitations of use.\u003c\/strong\u003e Do not use under 2 years of age for the treatment of chronic constipation and under 3 years of age for the treatment of fecal impaction: for these ages we recommend the bottle with measuring spoon. Taking the device is not recommended in case of intestinal perforation or obstruction due to structural or functional disorders of the intestinal wall, ileum, and in case of serious inflammatory pathologies of the intestinal tract such as Crohn's disease, ulcerative colitis and toxic megacolon, and in case of known hypersensitivity to PEG. Do not take the device while using other devices or oral medicinal products: the osmotic power of PEG and the increase in gastrointestinal transit speed can negatively affect their effectiveness. In any case, consult your doctor if you are undergoing other therapies. Do not use in case of known gastric or intestinal lesions.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDisposal.\u003c\/strong\u003e The device that has expired or that needs to be eliminated must be managed in accordance with the waste management regulations of the Local Management Authority. Do not dispose of the product or its packaging in the environment under any circumstances.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Pediapax 20 Sachets Constipation Powder for Children stored?\u003c\/h3\u003e\u003cp\u003eStore the package intact in a dry place away from direct light or heat sources: remove and open the bags only just before using them. Store the device below 25°C.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Pediapax 20 Sachets Constipation Powder for Children?\u003c\/h3\u003e\u003cp\u003e20 divisible sachets of 13.125 g of powder for oral suspension.\u003c\/p\u003e","brand":"Bioprojet","offers":[{"title":"Default Title","offer_id":54137682002247,"sku":"931449312","price":20.7,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/bioprojet-italia-srl-pediapax-polvere-20bust-farmacia-dottor-tili-1244017632.jpg?v=1781242841"},{"product_id":"clin-4000-macrogol-senza-elettroliti-lassativo-osmotico-30-bustine-monouso-da-10-g","title":"Clin 4000 Macrogol Without Electrolytes Osmotic Laxative 30 Disposable Sachets of 10 g","description":"\u003cp\u003e\u003cstrong\u003eClin 4000 Macrogol Without Electrolytes Osmotic Laxative 30 Disposable Sachets of 10 g\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e ad \u003cstrong\u003elaxative action\u003c\/strong\u003e in \u003cstrong\u003e30 disposable sachets\u003c\/strong\u003e: each contains \u003cstrong\u003e10 g\u003c\/strong\u003e of \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e and nothing else, because the formula does not have \u003cstrong\u003eexcipients\u003c\/strong\u003e, has no aromas and no sugars. It is used in \u003cstrong\u003echronic constipation\u003c\/strong\u003e and in cases of \u003cstrong\u003eoccasionally irregular bowel\u003c\/strong\u003e, and it is a macrogol \u003cstrong\u003ewithout electrolytes\u003c\/strong\u003e, which distinguishes it from most products of the same family.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e it is the only substance present, and it is worth knowing what that number means, because almost everyone reads it as a dosage and it is not. \u003cstrong\u003eMacrogol\u003c\/strong\u003e is the name that the \u003cstrong\u003eEuropean Pharmacopoeia\u003c\/strong\u003e gives to \u003cstrong\u003epolyethylene glycol\u003c\/strong\u003e, a polymer made of repeating units; the following number indicates the \u003cstrong\u003eaverage molecular weight\u003c\/strong\u003e of the espresso chain in \u003cstrong\u003edalton\u003c\/strong\u003e. Macrogol 4000 therefore means chains on average 4,000 daltons long: a large molecule, and the size is precisely the reason why it works the way it does. I \u003cstrong\u003e10 g\u003c\/strong\u003e of the sachet they are instead the quantity of substance, and they are the whole sachet.\u003c\/p\u003e\n\u003cp\u003eThe way he acts is \u003cstrong\u003ephysical\u003c\/strong\u003e, non-pharmacological, and you can feel the difference. Water molecules bind to the polymer to \u003cstrong\u003ehydrogen bond\u003c\/strong\u003e even before it reaches the intestine, and they remain attached: in the intestinal lumen the retained water increases the volume of the stool and softens its consistency. A \u003cstrong\u003eosmotic laxative\u003c\/strong\u003e as this does not affect the nerve plexuses of the wall or the muscles, which is what laxatives do instead \u003cstrong\u003estimulants\u003c\/strong\u003e or contact. The chain is too large to cross the mucosa, therefore \u003cstrong\u003eit is not absorbed\u003c\/strong\u003e, and is not a substrate for colon bacteria, therefore \u003cstrong\u003eit doesn't ferment\u003c\/strong\u003e: it is the reason why it does not produce the gas that accompanies sugar osmotics such as \u003cstrong\u003elactulose\u003c\/strong\u003e. \u003cstrong\u003eMacrogol 4000 is useful in cases of chronic constipation and occasionally irregular bowel movements.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe word \u003cstrong\u003ewithout electrolytes\u003c\/strong\u003e deserves its own line, because two different things with the same name coexist in the department. Different macrogols are formulated together with \u003cstrong\u003ego up\u003c\/strong\u003e (sodium, potassium, bicarbonate, chloride) which serve to maintain the balance of electrolytes when drinking a lot of liquid in one go: these are preparations designed for large volumes. \u003cstrong\u003eClin 4000\u003c\/strong\u003e it doesn't contain them: it just carries the polymer, and for this reason the powder doesn't have the salty taste that macrogols with electrolytes carry with them. It is also \u003cstrong\u003ewithout aroma\u003c\/strong\u003e, and this is not a shortcoming but the reason why it can be combined with any drink, from tea to broth to fruit juice, without changing its taste.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eClin 4000\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e in \u003cstrong\u003e30 disposable sachets\u003c\/strong\u003e, for \u003cstrong\u003e300 g\u003c\/strong\u003e total of macrogol 4000: the single-dose sachet avoids having to weigh the powder and the single wrapper remains closed until needed. The formula is \u003cstrong\u003esugar free\u003c\/strong\u003e, which matters to those keeping carbs under control, and it has no added excipients. In the same line there is the \u003cstrong\u003e200 g bottle\u003c\/strong\u003e with measuring spoon, the format that allows divided doses and is the one aimed at younger children: the MINSAN it looks a lot like the one in the sachets, so it's worth looking carefully at which one you're taking. Those looking for a pure macrogol, without salts and without flavourings, will find it in \u003cstrong\u003eClin 4000\u003c\/strong\u003e the most essential form.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should you use Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g? What is it for?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eClin 4000\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e ad \u003cstrong\u003elaxative action\u003c\/strong\u003e in \u003cstrong\u003e30 disposable sachets\u003c\/strong\u003e, each with \u003cstrong\u003e10 g\u003c\/strong\u003e of \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIt is used in \u003cstrong\u003echronic constipation\u003c\/strong\u003e and in cases of \u003cstrong\u003eoccasionally irregular bowel\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003emacrogol 4000\u003c\/strong\u003e it's a \u003cstrong\u003eosmotic laxative\u003c\/strong\u003e: retains water in the intestinal lumen and makes stool softer.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g contain?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eMacrogol 4000.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach sachet contains \u003cstrong\u003e10 g of macrogol 4000\u003c\/strong\u003e. It contains no excipients or flavourings. Without sugar.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g?\u003c\/h3\u003e\n\u003cp\u003eDissolve the powder by mixing in any drink. The contents of one sachet (10 g) must be dissolved in at least \u003cstrong\u003e125ml\u003c\/strong\u003e (increase to 150 ml in pediatric age) of any drink, even hot, such as tea, herbal teas, milk, broth or fruit juice. The product does not alter the taste of the drink. Drink the reconstituted solution. It is recommended to take between meals.\u003c\/p\u003e\n\u003cp\u003eDue to its safety features, it allows for wide dosing flexibility.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdults and children weighing more than 20 kg:\u003c\/strong\u003e 10 g (1 sachet), 1-3 times a day, according to individual response. To obtain a faster effect, the maximum daily dose (30 g) can be taken in a single administration. In case of prolonged use, the dose can be reduced to 10 g (1 sachet) 1-2 times a day, even every other day, preferably in the evening.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eChildren up to 20 kg:\u003c\/strong\u003e the dosage should be commensurate with body weight. We therefore recommend using the 200 g bottle of powder with measuring spoon, which allows you to customize the dose according to the child's real needs until soft stools are obtained. Do not exceed the maximum daily dosage of 30 g.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g?\u003c\/h3\u003e\n\u003cp\u003eDo not take in case of: known hypersensitivity to macrogol; gastrointestinal perforation and\/or obstruction.\u003c\/p\u003e\n\u003cp\u003eDuring pregnancy and breastfeeding the product must be used upon medical prescription.\u003c\/p\u003e\n\u003cp\u003eThere are no known interactions with drugs, but it is advisable to take the product at least 2 hours apart from that of oral drugs.\u003c\/p\u003e\n\u003cp\u003eOccasionally abdominal distension and\/or nausea may be noted, which resolve with continued use. Rare cases of allergic reactions (rash, urticaria): in this case, suspend use of the product and inform your doctor or pharmacist.\u003c\/p\u003e\n\u003cp\u003eIn case of overdose, diarrhea may occur, which resolves spontaneously upon discontinuation of the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g stored?\u003c\/h3\u003e\n\u003cp\u003eStore in the original packaging \u003cstrong\u003ecool and dry place\u003c\/strong\u003e. The expiry date indicated refers to the product in intact packaging and correctly stored.\u003c\/p\u003e\n\u003cp\u003eThe manufacturer also declares, in the European registration of the device, to maintain the product \u003cstrong\u003ebelow 25 °C\u003c\/strong\u003e, in a dry place and away from direct sources of heat or light.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Clin 4000 Macrogol 4000 Without Electrolytes 30 Disposable Sachets of 10 g?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e30 sachets of 10 g.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Shedir Pharma","offers":[{"title":"Default Title","offer_id":54137682493767,"sku":"931774119","price":21.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/shedir-pharma-srl-unipersonale-clin-4000-30bust-farmacia-dottor-tili-1244017616.jpg?v=1781241477"},{"product_id":"peginpol-20bust-10g","title":"Peginpol macrogol 3350 20 divisible sachets of 10 g","description":"\u003cp\u003eThe \u003cstrong\u003emacrogol 3350\u003c\/strong\u003e, which is also written as polyethylene glycol, is a large molecule that the intestine \u003cstrong\u003edoes not absorb\u003c\/strong\u003e and intestinal bacteria \u003cstrong\u003ethey don't ferment\u003c\/strong\u003e. It remains in the lumen and retains water with a \u003cstrong\u003eosmotic mechanism\u003c\/strong\u003e: the feces soften because they contain more water, and the transit starts again on its own. This is why it does not cause the cramps typical of laxatives that stimulate the intestinal wall to contract.\u003c\/p\u003e\u003cp\u003eThe fact that it does not ferment also explains the other difference that is noticed in its use: no bloating and no gas, which instead often accompany bulk laxatives based on fibre. It is the reason why macrogol has become the first choice in \u003cstrong\u003echronic constipation\u003c\/strong\u003e, even in young children, and for which the dosage here starts from \u003cstrong\u003e6 months\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eThe novelty of this format lies in the sachet. Contains \u003cstrong\u003e10 g\u003c\/strong\u003e, twice the size of the classic sachet, and it is \u003cstrong\u003edivisible\u003c\/strong\u003e: open two half doses of 5 g. A whole sachet dissolves in \u003cstrong\u003e125 ml of water\u003c\/strong\u003e, half in 62.5 ml. Thus, a single pack covers both the small child, who takes one or two 5 g doses a day, and the child or adult, who takes one to three full doses.\u003c\/p\u003e\u003cp\u003eThe box bill changes accordingly: \u003cstrong\u003e20 sachets of 10 g\u003c\/strong\u003e they do \u003cstrong\u003e200 g\u003c\/strong\u003e of product, double the 100 g of the previous package. The dust is \u003cstrong\u003egluten free\u003c\/strong\u003e e \u003cstrong\u003elactose free\u003c\/strong\u003e, and the product is a \u003cstrong\u003emedical device CE 0426\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Peginpol macrogol 3350 20 divisible sachets of 10 g used? What is it for?\u003c\/h3\u003e\u003cp\u003ePowder for \u003cstrong\u003eoral suspension\u003c\/strong\u003e useful in the treatment of \u003cstrong\u003echronic constipation\u003c\/strong\u003e and of the\u003cstrong\u003eoccasionally irregular bowel\u003c\/strong\u003e. It works with \u003cstrong\u003eosmotic mechanism\u003c\/strong\u003e, softening the stool without causing cramps or abdominal pain. Macrogol is not absorbed and does not ferment in the intestine. \u003cstrong\u003eMedical device CE 0426\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Peginpol macrogol 3350 20 divisible sachets of 10 g contain?\u003c\/h3\u003e\u003cp\u003eEach whole sachet contains \u003cstrong\u003e10 g of macrogol 3350\u003c\/strong\u003e. The sachet can be divided into two half doses of 5 g.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eExcipients:\u003c\/strong\u003e silicon dioxide, flavouring, sodium saccharin. Without \u003cstrong\u003egluten\u003c\/strong\u003e and without \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Peginpol macrogol 3350 20 divisible sachets of 10 g?\u003c\/h3\u003e\u003cp\u003eDissolve the contents of a whole sachet in \u003cstrong\u003e125 ml of water\u003c\/strong\u003e, or half a dose in 62.5 ml, stirring until completely dissolved. Take between meals.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDoses.\u003c\/strong\u003e From 6 months to 2 years, up to 12 kg: 5 g, once or twice a day. From 2 to 11 years, from 12 to 20 kg: 10 g, once or twice a day. Over 11 years and 20 kg: 10 g, one to three times a day.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Peginpol macrogol 3350 20 divisible sachets of 10 g?\u003c\/h3\u003e\u003cp\u003eNot recommended under 6 months. In pediatrics use only after medical consultation. Normally three sachets per day are not exceeded.\u003c\/p\u003e\u003cp\u003eGenerally well tolerated: initial gastrointestinal disorders or allergic reactions are rarely observed.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Peginpol macrogol 3350 20 divisible sachets of 10 g stored?\u003c\/h3\u003e\u003cp\u003eIn a cool, dry place, at no more than 25 degrees, in the original packaging.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Peginpol macrogol 3350 20 divisible sachets of 10 g?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003ePack of 20 divisible sachets of 10 g\u003c\/strong\u003e, per 200 g of net contents.\u003c\/p\u003e","brand":"BUONA SpA SOCIETA' BENEFIT","offers":[{"title":"Default Title","offer_id":54954304176455,"sku":"991044874","price":20.7,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/buona-spa-societa-benefit-peginpol-macrogol-3350-20-bustine-divisibili-da-10-g-farmacia-dottor-tili-1258975981.png?v=1789558271"}],"url":"https:\/\/www.dottortili.com\/en-eu\/collections\/drugs-and-laxative-devices-for-constipation.oembed","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}